000084263312/312024Q3FALSE40,571,662P5YP12YP15YP25YP1YP15YP17YP30Yone year0.00.60.65.05.0xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesiso4217:EURxbrli:pureutr:Ratetrs:casestrs:claimants00008426332024-01-012024-09-3000008426332024-10-2200008426332024-09-3000008426332023-12-3100008426332024-07-012024-09-3000008426332023-07-012023-09-3000008426332023-01-012023-09-3000008426332022-12-3100008426332023-09-300000842633us-gaap:CommonStockMember2023-12-310000842633us-gaap:AdditionalPaidInCapitalMember2023-12-310000842633us-gaap:RetainedEarningsMember2023-12-310000842633us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000842633us-gaap:RetainedEarningsMember2024-01-012024-03-3100008426332024-01-012024-03-310000842633us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000842633us-gaap:CommonStockMember2024-01-012024-03-310000842633us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310000842633us-gaap:CommonStockMember2024-03-310000842633us-gaap:AdditionalPaidInCapitalMember2024-03-310000842633us-gaap:RetainedEarningsMember2024-03-310000842633us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-3100008426332024-03-310000842633us-gaap:RetainedEarningsMember2024-04-012024-06-3000008426332024-04-012024-06-300000842633us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300000842633us-gaap:CommonStockMember2024-04-012024-06-300000842633us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300000842633us-gaap:CommonStockMember2024-06-300000842633us-gaap:AdditionalPaidInCapitalMember2024-06-300000842633us-gaap:RetainedEarningsMember2024-06-300000842633us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-3000008426332024-06-300000842633us-gaap:RetainedEarningsMember2024-07-012024-09-300000842633us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300000842633us-gaap:CommonStockMember2024-07-012024-09-300000842633us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300000842633us-gaap:CommonStockMember2024-09-300000842633us-gaap:AdditionalPaidInCapitalMember2024-09-300000842633us-gaap:RetainedEarningsMember2024-09-300000842633us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300000842633us-gaap:CommonStockMember2022-12-310000842633us-gaap:AdditionalPaidInCapitalMember2022-12-310000842633us-gaap:RetainedEarningsMember2022-12-310000842633us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000842633us-gaap:RetainedEarningsMember2023-01-012023-03-3100008426332023-01-012023-03-310000842633us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000842633us-gaap:CommonStockMember2023-01-012023-03-310000842633us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000842633us-gaap:CommonStockMember2023-03-310000842633us-gaap:AdditionalPaidInCapitalMember2023-03-310000842633us-gaap:RetainedEarningsMember2023-03-310000842633us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-3100008426332023-03-310000842633us-gaap:RetainedEarningsMember2023-04-012023-06-3000008426332023-04-012023-06-300000842633us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300000842633us-gaap:CommonStockMember2023-04-012023-06-300000842633us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300000842633us-gaap:CommonStockMember2023-06-300000842633us-gaap:AdditionalPaidInCapitalMember2023-06-300000842633us-gaap:RetainedEarningsMember2023-06-300000842633us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-3000008426332023-06-300000842633us-gaap:RetainedEarningsMember2023-07-012023-09-300000842633us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300000842633us-gaap:CommonStockMember2023-07-012023-09-300000842633us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300000842633us-gaap:CommonStockMember2023-09-300000842633us-gaap:AdditionalPaidInCapitalMember2023-09-300000842633us-gaap:RetainedEarningsMember2023-09-300000842633us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300000842633trs:ConsumercustomerendmarketMember2024-07-012024-09-300000842633trs:ConsumercustomerendmarketMember2023-07-012023-09-300000842633trs:ConsumercustomerendmarketMember2024-01-012024-09-300000842633trs:ConsumercustomerendmarketMember2023-01-012023-09-300000842633trs:AerospacecustomerendmarketMember2024-07-012024-09-300000842633trs:AerospacecustomerendmarketMember2023-07-012023-09-300000842633trs:AerospacecustomerendmarketMember2024-01-012024-09-300000842633trs:AerospacecustomerendmarketMember2023-01-012023-09-300000842633trs:IndustrialcustomerendmarketMember2024-07-012024-09-300000842633trs:IndustrialcustomerendmarketMember2023-07-012023-09-300000842633trs:IndustrialcustomerendmarketMember2024-01-012024-09-300000842633trs:IndustrialcustomerendmarketMember2023-01-012023-09-300000842633trs:RealignmentActionsMember2024-01-012024-09-300000842633trs:RealignmentActionsMember2024-07-012024-09-300000842633us-gaap:CostOfSalesMembertrs:RealignmentActionsMember2024-01-012024-09-300000842633us-gaap:CostOfSalesMembertrs:RealignmentActionsMember2024-07-012024-09-300000842633us-gaap:SellingGeneralAndAdministrativeExpensesMembertrs:RealignmentActionsMember2024-07-012024-09-300000842633us-gaap:SellingGeneralAndAdministrativeExpensesMembertrs:RealignmentActionsMember2024-01-012024-09-300000842633trs:RealignmentActionsMember2023-07-012023-09-300000842633trs:RealignmentActionsMember2023-01-012023-09-300000842633us-gaap:CostOfSalesMembertrs:RealignmentActionsMember2023-07-012023-09-300000842633us-gaap:SellingGeneralAndAdministrativeExpensesMembertrs:RealignmentActionsMember2023-07-012023-09-300000842633us-gaap:CostOfSalesMembertrs:RealignmentActionsMember2023-01-012023-09-300000842633us-gaap:SellingGeneralAndAdministrativeExpensesMembertrs:RealignmentActionsMember2023-01-012023-09-300000842633trs:WeldmacManufacturingCompanyMember2023-04-212023-04-210000842633trs:WeldmacManufacturingCompanyMember2023-04-210000842633trs:WeldmacManufacturingCompanyMember2022-01-012022-12-310000842633trs:WeldmacManufacturingCompanyMember2023-07-102023-07-100000842633trs:WeldmacManufacturingCompanyMember2024-09-300000842633trs:AartsPackagingBVMember2023-01-012023-03-310000842633trs:AartsPackagingBVMember2023-02-010000842633trs:AartsPackagingBVMember2022-01-012022-12-310000842633trs:PackagingReportableSegmentMember2023-12-310000842633trs:AerospaceReportableSegmentMember2023-12-310000842633trs:SpecialtyProductsReportableSegmentMember2023-12-310000842633trs:PackagingReportableSegmentMember2024-01-012024-09-300000842633trs:AerospaceReportableSegmentMember2024-01-012024-09-300000842633trs:SpecialtyProductsReportableSegmentMember2024-01-012024-09-300000842633trs:PackagingReportableSegmentMember2024-09-300000842633trs:AerospaceReportableSegmentMember2024-09-300000842633trs:SpecialtyProductsReportableSegmentMember2024-09-300000842633srt:MaximumMember2024-09-300000842633us-gaap:CustomerRelationshipsMembertrs:UsefulLifeFiveToTwelveYearsMember2024-09-300000842633us-gaap:CustomerRelationshipsMembertrs:UsefulLifeFiveToTwelveYearsMember2023-12-310000842633us-gaap:CustomerRelationshipsMembertrs:UsefulLifeFifteenToTwentyfiveYearsMember2024-09-300000842633us-gaap:CustomerRelationshipsMembertrs:UsefulLifeFifteenToTwentyfiveYearsMember2023-12-310000842633us-gaap:CustomerRelationshipsMember2024-09-300000842633us-gaap:CustomerRelationshipsMember2023-12-310000842633us-gaap:OtherIntangibleAssetsMembertrs:UsefulLifeOneToFifteenYearsMember2024-09-300000842633us-gaap:OtherIntangibleAssetsMembertrs:UsefulLifeOneToFifteenYearsMember2023-12-310000842633us-gaap:OtherIntangibleAssetsMembertrs:UsefulLifeSeventeenToThirtyYearsMember2024-09-300000842633us-gaap:OtherIntangibleAssetsMembertrs:UsefulLifeSeventeenToThirtyYearsMember2023-12-310000842633us-gaap:OtherIntangibleAssetsMember2024-09-300000842633us-gaap:OtherIntangibleAssetsMember2023-12-310000842633us-gaap:TrademarksAndTradeNamesMember2024-09-300000842633us-gaap:TrademarksAndTradeNamesMember2023-12-310000842633us-gaap:OtherIntangibleAssetsMemberus-gaap:CostOfSalesMember2024-07-012024-09-300000842633us-gaap:OtherIntangibleAssetsMemberus-gaap:CostOfSalesMember2023-07-012023-09-300000842633us-gaap:OtherIntangibleAssetsMemberus-gaap:CostOfSalesMember2024-01-012024-09-300000842633us-gaap:OtherIntangibleAssetsMemberus-gaap:CostOfSalesMember2023-01-012023-09-300000842633us-gaap:CustomerRelationshipsMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2024-07-012024-09-300000842633us-gaap:CustomerRelationshipsMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012023-09-300000842633us-gaap:CustomerRelationshipsMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2024-01-012024-09-300000842633us-gaap:CustomerRelationshipsMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-09-300000842633us-gaap:CustomerRelationshipsMembertrs:UsefulLifeFiveToTwelveYearsMembersrt:MinimumMember2024-09-300000842633us-gaap:CustomerRelationshipsMembertrs:UsefulLifeFiveToTwelveYearsMembersrt:MaximumMember2024-09-300000842633us-gaap:CustomerRelationshipsMembertrs:UsefulLifeFifteenToTwentyfiveYearsMembersrt:MinimumMember2024-09-300000842633us-gaap:CustomerRelationshipsMembertrs:UsefulLifeFifteenToTwentyfiveYearsMembersrt:MaximumMember2024-09-300000842633us-gaap:OtherIntangibleAssetsMembertrs:UsefulLifeOneToFifteenYearsMembersrt:MinimumMember2024-09-300000842633us-gaap:OtherIntangibleAssetsMembertrs:UsefulLifeOneToFifteenYearsMembersrt:MaximumMember2024-09-300000842633us-gaap:OtherIntangibleAssetsMembertrs:UsefulLifeSeventeenToThirtyYearsMembersrt:MinimumMember2024-09-300000842633us-gaap:OtherIntangibleAssetsMembertrs:UsefulLifeSeventeenToThirtyYearsMembersrt:MaximumMember2024-09-300000842633srt:MinimumMember2024-09-300000842633us-gaap:LandAndLandImprovementsMember2024-09-300000842633us-gaap:LandAndLandImprovementsMember2023-12-310000842633us-gaap:BuildingMember2024-09-300000842633us-gaap:BuildingMember2023-12-310000842633us-gaap:MachineryAndEquipmentMember2024-09-300000842633us-gaap:MachineryAndEquipmentMember2023-12-310000842633us-gaap:CostOfSalesMemberus-gaap:SegmentContinuingOperationsMember2024-07-012024-09-300000842633us-gaap:CostOfSalesMemberus-gaap:SegmentContinuingOperationsMember2023-07-012023-09-300000842633us-gaap:CostOfSalesMemberus-gaap:SegmentContinuingOperationsMember2024-01-012024-09-300000842633us-gaap:CostOfSalesMemberus-gaap:SegmentContinuingOperationsMember2023-01-012023-09-300000842633us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:SegmentContinuingOperationsMember2024-07-012024-09-300000842633us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:SegmentContinuingOperationsMember2023-07-012023-09-300000842633us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:SegmentContinuingOperationsMember2024-01-012024-09-300000842633us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:SegmentContinuingOperationsMember2023-01-012023-09-300000842633us-gaap:SegmentContinuingOperationsMember2024-07-012024-09-300000842633us-gaap:SegmentContinuingOperationsMember2023-07-012023-09-300000842633us-gaap:SegmentContinuingOperationsMember2024-01-012024-09-300000842633us-gaap:SegmentContinuingOperationsMember2023-01-012023-09-300000842633trs:A4125SeniorUnsecuredNotesDue2029Member2024-09-300000842633trs:A4125SeniorUnsecuredNotesDue2029Member2023-12-310000842633trs:CreditAgreementMember2024-09-300000842633trs:CreditAgreementMember2023-12-310000842633trs:A4125SeniorUnsecuredNotesDue2029Memberus-gaap:SeniorNotesMember2024-09-300000842633trs:A4125SeniorUnsecuredNotesDue2029Memberus-gaap:SeniorNotesMember2024-07-012024-09-300000842633trs:A4125SeniorUnsecuredNotesDue2029Memberus-gaap:SeniorNotesMemberus-gaap:DebtInstrumentRedemptionPeriodTwoMember2024-01-012024-09-300000842633trs:A4125SeniorUnsecuredNotesDue2029Memberus-gaap:SeniorNotesMemberus-gaap:DebtInstrumentRedemptionPeriodThreeMember2024-01-012024-09-300000842633trs:A4125SeniorUnsecuredNotesDue2029Memberus-gaap:SeniorNotesMemberus-gaap:DebtInstrumentRedemptionPeriodFourMember2024-01-012024-09-300000842633us-gaap:RevolvingCreditFacilityMember2024-09-300000842633us-gaap:RevolvingCreditFacilityMember2024-09-300000842633us-gaap:RevolvingCreditFacilityMember2024-07-012024-09-300000842633us-gaap:GeographicDistributionForeignMemberus-gaap:RevolvingCreditFacilityMember2024-07-012024-09-300000842633us-gaap:GeographicDistributionDomesticMemberus-gaap:RevolvingCreditFacilityMember2024-07-012024-09-300000842633us-gaap:LetterOfCreditMember2024-09-300000842633trs:RevolvingCreditAndTermLoanFacilitiesMember2024-09-300000842633us-gaap:RevolvingCreditFacilityMember2023-12-310000842633us-gaap:LetterOfCreditMember2023-12-310000842633us-gaap:NonUsMemberus-gaap:RevolvingCreditFacilityMember2024-09-300000842633us-gaap:NonUsMemberus-gaap:RevolvingCreditFacilityMember2023-12-310000842633us-gaap:FairValueInputsLevel2Membertrs:A4125SeniorUnsecuredNotesDue2029Member2024-09-300000842633us-gaap:FairValueInputsLevel2Membertrs:A4125SeniorUnsecuredNotesDue2029Member2023-12-310000842633trs:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2024-09-300000842633us-gaap:FairValueInputsLevel2Membertrs:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2024-09-300000842633trs:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2023-12-310000842633us-gaap:FairValueInputsLevel2Membertrs:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2023-12-310000842633us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembertrs:June2024DerivativeDomain2024-09-300000842633us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembertrs:February2024DerivativeContractDateDomain2024-09-300000842633trs:February2024DerivativeContractDateDomainus-gaap:CrossCurrencyInterestRateContractMember2024-02-150000842633us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMembertrs:February2024DerivativeContractDateDomain2024-02-150000842633us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:NondesignatedMember2024-09-300000842633us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:NondesignatedMember2024-04-150000842633us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesMember2024-09-300000842633us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:AccruedLiabilitiesMember2023-12-310000842633us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesMember2024-09-300000842633us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherLiabilitiesMember2023-12-310000842633us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-300000842633us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310000842633us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-07-012024-09-300000842633us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-07-012023-09-300000842633us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-09-300000842633us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-09-300000842633us-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-09-300000842633us-gaap:DesignatedAsHedgingInstrumentMember2024-07-012024-09-300000842633us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-09-300000842633us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-07-012024-09-300000842633us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-07-012023-09-300000842633us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-01-012024-09-300000842633us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-01-012023-09-300000842633us-gaap:CurrencySwapMemberus-gaap:NondesignatedMember2024-07-012024-09-300000842633us-gaap:CurrencySwapMemberus-gaap:NondesignatedMember2023-07-012023-09-300000842633us-gaap:CurrencySwapMemberus-gaap:NondesignatedMember2024-01-012024-09-300000842633us-gaap:CurrencySwapMemberus-gaap:NondesignatedMember2023-01-012023-09-300000842633us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000842633us-gaap:FairValueInputsLevel1Memberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000842633us-gaap:FairValueInputsLevel2Memberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000842633us-gaap:FairValueInputsLevel3Memberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000842633us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMember2024-09-300000842633us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000842633us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000842633us-gaap:FairValueInputsLevel3Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300000842633us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000842633us-gaap:FairValueInputsLevel1Memberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000842633us-gaap:FairValueInputsLevel2Memberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000842633us-gaap:FairValueInputsLevel3Memberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000842633us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMember2023-12-310000842633us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000842633us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000842633us-gaap:FairValueInputsLevel3Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310000842633us-gaap:AsbestosIssueMember2024-09-300000842633us-gaap:AsbestosIssueMember2023-12-310000842633us-gaap:AsbestosIssueMember2024-01-012024-09-300000842633us-gaap:AsbestosIssueMember2022-12-310000842633us-gaap:AsbestosIssueMember2023-01-012023-12-310000842633us-gaap:AsbestosIssueMemberus-gaap:PendingLitigationMembertrs:CompensatoryOnlyDamagesMember2024-09-300000842633us-gaap:AsbestosIssueMembertrs:PunitiveOnlyDamagesMembersrt:MinimumMember2024-07-012024-09-300000842633us-gaap:AsbestosIssueMemberus-gaap:PendingLitigationMembertrs:Range1Membertrs:CompensatoryOnlyDamagesMember2024-09-300000842633us-gaap:AsbestosIssueMemberus-gaap:PendingLitigationMembertrs:Range2Membertrs:CompensatoryOnlyDamagesMember2024-09-300000842633us-gaap:AsbestosIssueMemberus-gaap:PendingLitigationMembertrs:Range3Membertrs:CompensatoryOnlyDamagesMember2024-09-300000842633us-gaap:AsbestosIssueMember1991-01-012024-09-300000842633us-gaap:AsbestosIssueMembersrt:MinimumMember2024-09-300000842633us-gaap:AsbestosIssueMembersrt:MaximumMember2024-09-300000842633us-gaap:AsbestosIssueMember2024-07-012024-09-300000842633us-gaap:EnvironmentalIssueMember2024-07-012024-09-300000842633us-gaap:EnvironmentalIssueMember2024-01-012024-09-300000842633us-gaap:EnvironmentalIssueMember2024-09-300000842633us-gaap:AsbestosIssueMembertrs:Range1Membertrs:CompensatoryOnlyDamagesMembersrt:MinimumMember2024-01-012024-09-300000842633us-gaap:AsbestosIssueMembertrs:Range1Membertrs:CompensatoryOnlyDamagesMembersrt:MaximumMember2024-01-012024-09-300000842633us-gaap:AsbestosIssueMembertrs:Range2Membertrs:CompensatoryOnlyDamagesMembersrt:MinimumMember2024-01-012024-09-300000842633us-gaap:AsbestosIssueMembertrs:Range2Membertrs:CompensatoryOnlyDamagesMembersrt:MaximumMember2024-01-012024-09-300000842633us-gaap:AsbestosIssueMembertrs:Range3Membertrs:CompensatoryOnlyDamagesMembersrt:MinimumMember2024-01-012024-09-300000842633us-gaap:OperatingSegmentsMembertrs:PackagingReportableSegmentMember2024-07-012024-09-300000842633us-gaap:OperatingSegmentsMembertrs:PackagingReportableSegmentMember2023-07-012023-09-300000842633us-gaap:OperatingSegmentsMembertrs:PackagingReportableSegmentMember2024-01-012024-09-300000842633us-gaap:OperatingSegmentsMembertrs:PackagingReportableSegmentMember2023-01-012023-09-300000842633us-gaap:OperatingSegmentsMembertrs:AerospaceReportableSegmentMember2024-07-012024-09-300000842633us-gaap:OperatingSegmentsMembertrs:AerospaceReportableSegmentMember2023-07-012023-09-300000842633us-gaap:OperatingSegmentsMembertrs:AerospaceReportableSegmentMember2024-01-012024-09-300000842633us-gaap:OperatingSegmentsMembertrs:AerospaceReportableSegmentMember2023-01-012023-09-300000842633us-gaap:OperatingSegmentsMembertrs:SpecialtyProductsReportableSegmentMember2024-07-012024-09-300000842633us-gaap:OperatingSegmentsMembertrs:SpecialtyProductsReportableSegmentMember2023-07-012023-09-300000842633us-gaap:OperatingSegmentsMembertrs:SpecialtyProductsReportableSegmentMember2024-01-012024-09-300000842633us-gaap:OperatingSegmentsMembertrs:SpecialtyProductsReportableSegmentMember2023-01-012023-09-300000842633us-gaap:OperatingSegmentsMember2024-07-012024-09-300000842633us-gaap:OperatingSegmentsMember2023-07-012023-09-300000842633us-gaap:OperatingSegmentsMember2024-01-012024-09-300000842633us-gaap:OperatingSegmentsMember2023-01-012023-09-300000842633us-gaap:CorporateNonSegmentMember2024-07-012024-09-300000842633us-gaap:CorporateNonSegmentMember2023-07-012023-09-300000842633us-gaap:CorporateNonSegmentMember2024-01-012024-09-300000842633us-gaap:CorporateNonSegmentMember2023-01-012023-09-300000842633us-gaap:RestrictedStockUnitsRSUMembertrs:Plan1Member2024-01-012024-09-300000842633us-gaap:RestrictedStockUnitsRSUMembertrs:Plan7Member2024-01-012024-09-300000842633us-gaap:RestrictedStockUnitsRSUMemberus-gaap:DividendDeclaredMember2024-01-012024-09-300000842633us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-09-300000842633us-gaap:RestrictedStockUnitsRSUMembertrs:Plan8Member2024-01-012024-09-300000842633trs:Plan8Memberus-gaap:RestrictedStockUnitsRSUMembertrs:A3YearEpsCagrMetricMembersrt:MaximumMember2024-01-012024-09-300000842633trs:Plan8Memberus-gaap:RestrictedStockUnitsRSUMembertrs:CashReturnOnNetAssetsMetricMembersrt:MaximumMember2024-01-012024-09-300000842633trs:Plan8Memberus-gaap:RestrictedStockUnitsRSUMembertrs:TotalshareholderreturnmetricMembersrt:MinimumMember2024-01-012024-09-300000842633trs:Plan8Memberus-gaap:RestrictedStockUnitsRSUMembertrs:TotalshareholderreturnmetricMembersrt:MaximumMember2024-01-012024-09-300000842633us-gaap:RestrictedStockUnitsRSUMember2023-12-310000842633us-gaap:RestrictedStockUnitsRSUMember2024-09-300000842633us-gaap:RestrictedStockUnitsRSUMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2024-07-012024-09-300000842633us-gaap:RestrictedStockUnitsRSUMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012023-09-300000842633us-gaap:RestrictedStockUnitsRSUMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2024-01-012024-09-300000842633us-gaap:RestrictedStockUnitsRSUMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-09-300000842633us-gaap:RestrictedStockUnitsRSUMember2024-07-012024-09-300000842633us-gaap:RestrictedStockUnitsRSUMember2023-07-012023-09-300000842633us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300000842633trs:A10b51sharerepurchaseprogramMember2024-09-300000842633trs:A10b51sharerepurchaseprogramMember2024-07-012024-09-300000842633trs:A10b51sharerepurchaseprogramMember2024-01-012024-09-300000842633trs:A10b51sharerepurchaseprogramMember2023-07-012023-09-300000842633trs:A10b51sharerepurchaseprogramMember2023-01-012023-09-300000842633us-gaap:PensionPlansDefinedBenefitMember2024-07-012024-09-300000842633us-gaap:PensionPlansDefinedBenefitMember2023-07-012023-09-300000842633us-gaap:PensionPlansDefinedBenefitMember2024-01-012024-09-300000842633us-gaap:PensionPlansDefinedBenefitMember2023-01-012023-09-300000842633us-gaap:PensionPlansDefinedBenefitMember2024-09-300000842633us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310000842633trs:AccumulatedNetGainLossfromHedgesAttributabletoParentMember2023-12-310000842633us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310000842633us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-09-300000842633trs:AccumulatedNetGainLossfromHedgesAttributabletoParentMember2024-01-012024-09-300000842633us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-09-300000842633us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300000842633us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-09-300000842633trs:AccumulatedNetGainLossfromHedgesAttributabletoParentMember2024-09-300000842633us-gaap:AccumulatedTranslationAdjustmentMember2024-09-300000842633us-gaap:CrossCurrencyInterestRateContractMember2024-01-012024-09-300000842633us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310000842633trs:AccumulatedNetGainLossfromHedgesAttributabletoParentMember2022-12-310000842633us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000842633us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-09-300000842633trs:AccumulatedNetGainLossfromHedgesAttributabletoParentMember2023-01-012023-09-300000842633us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-09-300000842633us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300000842633us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-09-300000842633trs:AccumulatedNetGainLossfromHedgesAttributabletoParentMember2023-09-300000842633us-gaap:AccumulatedTranslationAdjustmentMember2023-09-300000842633us-gaap:CrossCurrencyInterestRateContractMember2023-01-012023-09-300000842633us-gaap:SubsequentEventMember2024-10-252024-10-250000842633trs:WeldmacManufacturingCompanyMemberus-gaap:SubsequentEventMember2024-10-250000842633us-gaap:SubsequentEventMemberus-gaap:DividendDeclaredMember2024-10-222024-10-220000842633us-gaap:SubsequentEventMemberus-gaap:DividendDeclaredMember2024-10-22

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON D.C. 20549

FORM 10-Q

(Mark One)
☒						Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the Quarterly Period Ended									September 30, 2024
Or
☐						Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the Transition Period from                  to                  .

Commission file number 001-10716

TRIMAS CORPORATION

(Exact name of registrant as specified in its charter)

Delaware						38-2687639
(State or other jurisdiction of incorporation or organization)						(IRS Employer Identification No.)

38505 Woodward Avenue, Suite 200

Bloomfield Hills, Michigan 48304

(Address of principal executive offices, including zip code)

(248) 631-5450

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading symbol(s)			Name of exchange on which registered
Common stock, $0.01 par value			TRS			The NASDAQ Stock Market LLC

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒    No ☐.

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒    No ☐.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐    No ☒

As of October 22, 2024, the number of outstanding shares of the Registrant's common stock, $0.01 par value, was 40,571,662 shares.

---

Table of Contents

TriMas Corporation

Index

Part I.

Financial Information

Forward-Looking Statements

2

Item 1.

Consolidated Financial Statements

3

Consolidated Balance Sheet as of September 30, 2024 and December 31, 2023

3

Consolidated Statement of Income for the Three and Nine Months Ended September 30, 2024 and 2023

4

Consolidated Statement of Comprehensive Income for the Three and Nine Months Ended September 30, 2024 and 2023

5

Consolidated Statement of Cash Flows for the Nine Months Ended September 30, 2024 and 2023

6

Consolidated Statement of Shareholders' Equity for the Nine Months Ended September 30, 2024 and 2023

7

Notes to Consolidated Financial Statements

9

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

25

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

42

Item 4.

Controls and Procedures

42

Part II.

Other Information

Item 1.

Legal Proceedings

43

Item 1A.

Risk Factors

43

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

43

Item 3.

Defaults Upon Senior Securities

43

Item 4.

Mine Safety Disclosures

43

Item 5.

Other Information

43

Item 6.

Exhibits

44

Signatures

45

1

---

Table of Contents

Forward-Looking Statements

This report may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 about our financial condition, results of operations and business. These forward-looking statements can be identified by the use of forward-looking words, such as “may,” “could,” “should,” “estimate,” “project,” “forecast,” “intend,” “expect,” “anticipate,” “believe,” “target,” “plan” or other comparable words, or by discussions of strategy that may involve risks and uncertainties.

These forward-looking statements are subject to numerous assumptions, risks and uncertainties which could materially affect our business, financial condition or future results including, but not limited to: general economic and currency conditions; competitive factors; market demand; our ability to realize our business strategies; our ability to identify attractive acquisition candidates, successfully integrate acquired operations or realize the intended benefits of such acquisitions; pressures on our supply chain, including availability of raw materials and inflationary pressures on raw material and energy costs, and customers; the performance of our subcontractors and suppliers; risks and uncertainties associated with intangible assets, including goodwill or other intangible asset impairment charges; risks associated with a concentrated customer base; information technology and other cyber-related risks; risks related to our international operations, including, but not limited to, risks relating to tensions between the United States and China; government and regulatory actions, including, without limitation, climate change legislation and other environmental regulations, as well as the impact of tariffs, quotas and surcharges; changes to fiscal and tax policies; intellectual property factors; uncertainties associated with our ability to meet customers’ and suppliers’ sustainability and environmental, social and governance ("ESG") goals and achieve our sustainability and ESG goals in alignment with our own announced targets; litigation; contingent liabilities relating to acquisition activities; interest rate volatility; our leverage; liabilities imposed by our debt instruments; labor disputes and shortages; the disruption of operations from catastrophic or extraordinary events, including, but not limited to, natural disasters, geopolitical conflicts and public health crises; the amount and timing of future dividends and/or share repurchases, which remain subject to Board approval and depend on market and other conditions; our future prospects; our ability to successfully complete the sale of our Arrow Engine business; and other risks that are discussed in Part I, Item 1A, "Risk Factors," in our Annual Report on Form 10-K for the year ended December 31, 2023 and elsewhere in this report. The risks described in our Annual Report on Form 10-K and elsewhere in this report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deemed to be immaterial also may materially adversely affect our business, financial position and results of operations or cash flows.

The cautionary statements set forth above should be considered in connection with any subsequent written or oral forward-looking statements that we or persons acting on our behalf may issue. We caution readers not to place undue reliance on the statements, which speak only as of the date of this report. We do not undertake any obligation to review or confirm analysts' expectations or estimates or to release publicly any revisions to any forward-looking statement to reflect events or circumstances after the date of this report or to reflect the occurrence of unanticipated events, except as required by law.

We disclose important factors that could cause our actual results to differ materially from our expectations implied by our forward-looking statements under Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations," in our Annual Report on Form 10-K for the year ended December 31, 2023 and elsewhere in this report. These cautionary statements qualify all forward-looking statements attributed to us or persons acting on our behalf. When we indicate that an event, condition or circumstance could or would have an adverse effect on us, we mean to include effects upon our business, financial and other conditions, results of operations, prospects and ability to service our debt.

2

---

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1.    Consolidated Financial Statements

TriMas Corporation

Consolidated Balance Sheet

(Dollars in thousands)

						September 30, 2024						December 31, 2023
Assets						(unaudited)
Current assets:
Cash and cash equivalents						$	26,910					$	34,890
Receivables, net of reserves of $4.5 million and $4.2 million as of September 30, 2024 and December 31, 2023, respectively						163,260						148,030
Inventories						213,880						192,450
Prepaid expenses and other current assets						31,290						22,010
Total current assets						435,340						397,380
Property and equipment, net						329,310						329,990
Operating lease right-of-use assets						42,220						43,220
Goodwill						365,100						363,770
Other intangibles, net						168,650						181,020
Deferred income taxes						10,370						10,230
Other assets						16,840						16,050
Total assets						$	1,367,830					$	1,341,660
Liabilities and Shareholders' Equity
Current liabilities:
Short-term borrowings						$	80					$	—
Accounts payable						80,800						91,910
Accrued liabilities						65,210						59,640
Lease liabilities, current portion						7,900						7,900
Total current liabilities						153,990						159,450
Long-term debt, net						409,870						395,660
Lease liabilities						38,650						39,690
Deferred income taxes						26,820						23,290
Other long-term liabilities						55,750						40,620
Total liabilities						685,080						658,710
Preferred stock, $0.01 par: Authorized 100,000,000 shares; Issued and outstanding: None						—						—
Common stock, $0.01 par: Authorized 400,000,000 shares; Issued and outstanding: 40,563,351 shares at September 30, 2024 and 41,202,110 shares at December 31, 2023						410						410
Paid-in capital						665,000						677,660
Retained earnings						17,680						4,230
Accumulated other comprehensive income (loss)						(340)						650
Total shareholders' equity						682,750						682,950
Total liabilities and shareholders' equity						$	1,367,830					$	1,341,660

The accompanying notes are an integral part of these consolidated financial statements.

3

---

Table of Contents

TriMas Corporation

Consolidated Statement of Income

(Unaudited—dollars in thousands, except for per share amounts)

						Three months ended September 30,												Nine months ended September 30,
						2024						2023						2024						2023
Net sales						$	229,360					$	235,340					$	696,960					$	683,990
Cost of sales						(177,660)						(179,410)						(538,540)						(525,840)
Gross profit						51,700						55,930						158,420						158,150
Selling, general and administrative expenses						(44,460)						(32,290)						(120,890)						(104,410)
Net gain on dispositions of assets						1,040						120						1,040						70
Operating profit						8,280						23,760						38,570						53,810
Other expense, net:
Interest expense						(4,860)						(3,950)						(15,010)						(11,620)
Other income (expense), net						(30)						(120)						(310)						(30)
Other expense, net						(4,890)						(4,070)						(15,320)						(11,650)
Income before income tax expense						3,390						19,690						23,250						42,160
Income tax expense						(860)						(3,200)						(4,640)						(9,740)
Net income						$	2,530					$	16,490					$	18,610					$	32,420
Basic earnings per share:
Net income per share						$	0.06					$	0.40					$	0.46					$	0.78
Weighted average common shares—basic						40,612,413						41,425,208						40,776,583						41,477,095
Diluted earnings per share:
Net income per share						$	0.06					$	0.40					$	0.45					$	0.78
Weighted average common shares—diluted						40,946,571						41,673,381						41,089,208						41,706,867

The accompanying notes are an integral part of these consolidated financial statements.

4

---

Table of Contents

TriMas Corporation

Consolidated Statement of Comprehensive Income

(Unaudited—dollars in thousands)

						Three months ended September 30,												Nine months ended September 30,
						2024						2023						2024						2023
Net income						$	2,530					$	16,490					$	18,610					$	32,420
Other comprehensive income (loss):
Defined benefit plans (Note 17)						40						10						90						780
Foreign currency translation						10,510						(8,360)						1,560						1,060
Derivative instruments (Note 10)						(3,750)						3,380						(2,640)						630
Total other comprehensive income (loss)						6,800						(4,970)						(990)						2,470
Total comprehensive income						$	9,330					$	11,520					$	17,620					$	34,890

The accompanying notes are an integral part of these consolidated financial statements.

5

---

Table of Contents

TriMas Corporation

Consolidated Statement of Cash Flows

(Unaudited—dollars in thousands)

						Nine months ended September 30,
						2024						2023
Cash Flows from Operating Activities:
Net income						$	18,610					$	32,420
Adjustments to reconcile net income to net cash provided by operating activities, net of acquisition impact:
Gain on dispositions of assets						(1,040)						(70)
Depreciation						29,940						29,830
Amortization of intangible assets						12,640						13,810
Amortization of debt issue costs						720						700
Deferred income taxes						3,540						2,650
Non-cash compensation expense						8,050						9,320
Provision for losses on accounts receivable						290						—
Change in asbestos liability estimate						5,510						—
Change in environmental liability estimate						2,490						—
Increase in receivables						(15,910)						(22,580)
(Increase) decrease in inventories						(23,050)						1,800
Increase in prepaid expenses and other assets						(4,570)						(660)
Decrease in accounts payable and accrued liabilities						(7,020)						(10,390)
Other operating activities						6,500						740
Net cash provided by operating activities, net of acquisition impact						36,700						57,570
Cash Flows from Investing Activities:
Capital expenditures						(35,980)						(34,940)
Acquisition of businesses, net of cash acquired						—						(77,340)
Cross-currency swap terminations						(3,760)						—
Settlement of foreign currency exchange forward contract						3,760						—
Net proceeds from disposition of property and equipment						4,100						460
Net cash used for investing activities						(31,880)						(111,820)
Cash Flows from Financing Activities:
Proceeds from borrowings on revolving credit facilities						248,730						74,410
Repayments of borrowings on revolving credit facilities						(235,380)						(73,350)
Payments to purchase common stock						(19,270)						(13,350)
Shares surrendered upon exercise and vesting of equity awards to cover taxes						(1,620)						(2,680)
Dividends paid						(4,980)						(5,020)
Other financing activities						(280)						(3,190)
Net cash used for financing activities						(12,800)						(23,180)
Cash and Cash Equivalents:
Decrease for the period						(7,980)						(77,430)
At beginning of period						34,890						112,090
At end of period						$	26,910					$	34,660
Supplemental disclosure of cash flow information:
Cash paid for interest						$	9,860					$	7,560
Cash paid for taxes						$	9,080					$	11,020

        

The accompanying notes are an integral part of these consolidated financial statements.

6

---

Table of Contents

TriMas Corporation

Consolidated Statement of Shareholders' Equity

Nine Months Ended September 30, 2024 and 2023

(Unaudited—dollars in thousands)

						Common Stock						Paid-in Capital						Retained Earnings						Accumulated Other Comprehensive Income (Loss)						Total
Balances, December 31, 2023						$	410					$	677,660					$	4,230					$	650					$	682,950
Net income						—						—						5,140						—						5,140
Other comprehensive loss						—						—						—						(2,900)						(2,900)
Purchase of common stock						—						(13,240)						(80)						—						(13,320)
Shares surrendered upon exercise and vesting of equity awards to cover taxes						—						(1,560)						—						—						(1,560)
Non-cash compensation expense						—						4,570						—						—						4,570
Dividends declared						—						—						(1,660)						—						(1,660)
Balances, March 31, 2024						$	410					$	667,430					$	7,630					$	(2,250)					$	673,220
Net income						—						—						10,940						—						10,940
Other comprehensive loss						—						—						—						(4,890)						(4,890)
Purchase of common stock						—						(3,490)						(40)						—						(3,530)
Non-cash compensation expense						—						1,850						—						—						1,850
Dividends declared						—						—						(1,660)						—						(1,660)
Balances, June 30, 2024						$	410					$	665,790					$	16,870					$	(7,140)					$	675,930
Net income						—						—						2,530						—						2,530
Other comprehensive income						—						—						—						6,800						6,800
Purchase of common stock						—						(2,360)						(60)						—						(2,420)
Shares surrendered upon exercise and vesting of equity awards to cover taxes						—						(60)						—						—						(60)
Non-cash compensation expense						—						1,630						—						—						1,630
Dividends declared						—						—						(1,660)						—						(1,660)
Balances, September 30, 2024						$	410					$	665,000					$	17,680					$	(340)					$	682,750

The accompanying notes are an integral part of these consolidated financial statements.

7

---

Table of Contents

TriMas Corporation

Consolidated Statement of Shareholders' Equity (Continued)

Nine Months Ended September 30, 2024 and 2023

(Unaudited—dollars in thousands)

						Common Stock						Paid-in Capital						Accumulated Deficit						Accumulated Other Comprehensive Income (Loss)						Total
Balances, December 31, 2022						$	420					$	696,160					$	(36,130)					$	(8,620)					$	651,830
Net income						—						—						4,910						—						4,910
Other comprehensive income						—						—						—						3,450						3,450
Purchase of common stock						—						(10,400)						—						—						(10,400)
Shares surrendered upon exercise and vesting of equity awards to cover taxes						—						(2,310)						—						—						(2,310)
Non-cash compensation expense						—						2,940						—						—						2,940
Dividends declared						—						(1,660)						—						—						(1,660)
Balances, March 31, 2023						$	420					$	684,730					$	(31,220)					$	(5,170)					$	648,760
Net income						—						—						11,020						—						11,020
Other comprehensive income						—						—						—						3,990						3,990
Purchase of common stock						(10)						(2,680)						—						—						(2,690)
Shares surrendered upon exercise and vesting of equity awards to cover taxes						—						(280)						—						—						(280)
Non-cash compensation expense						—						3,240						—						—						3,240
Dividends declared						—						(1,680)						—						—						(1,680)
Balances, June 30, 2023						$	410					$	683,330					$	(20,200)					$	(1,180)					$	662,360
Net income						—						—						16,490						—						16,490
Other comprehensive loss						—						—						—						(4,970)						(4,970)
Purchase of common stock						—						(260)						—						—						(260)
Shares surrendered upon exercise and vesting of equity awards to cover taxes						—						(90)						—						—						(90)
Non-cash compensation expense						—						3,140						—						—						3,140
Dividends declared						—						(1,680)						—						—						(1,680)
Balances, September 30, 2023						$	410					$	684,440					$	(3,710)					$	(6,150)					$	674,990

The accompanying notes are an integral part of these consolidated financial statements.

8

---

Table of Contents

TRIMAS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

1. Basis of Presentation

TriMas Corporation ("TriMas" or the "Company"), and its consolidated subsidiaries, designs, engineers and manufactures innovative products under leading brand names for customers primarily in the consumer products, aerospace & defense, and industrial markets.

The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries and, in the opinion of management, contain all adjustments, including adjustments of a normal and recurring nature, necessary for a fair presentation of financial position and results of operations. The preparation of financial statements requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities. Actual results may differ from such estimates and assumptions due to risks and uncertainties, including uncertainty and volatility in the current economic environment due to input cost inflation, supply chain disruptions, and shortages in global markets for commodities, logistics and labor. To the extent there are differences between these estimates and actual results, the Company's consolidated financial statements may be materially affected.

Results of operations for interim periods are not necessarily indicative of results for the full year. The accompanying consolidated financial statements and notes thereto should be read in conjunction with the Company's 2023 Annual Report on Form 10-K.

2. New Accounting Pronouncements

Recently Issued Accounting Pronouncements

In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures" ("ASU 2023-09"), which requires enhanced jurisdictional disclosures for income taxes paid and requires the use of specific categories in the effective tax rate reconciliation as well as additional information for reconciling items that meet a quantitative threshold. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is in the process of assessing the impact of adoption on its consolidated financial statements.

In November 2023, the FASB issued ASU 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" ("ASU 2023-07"), which requires disclosure of significant segment expenses and other segment items by reportable segment on an annual and interim basis, the title and position of chief operating decision maker ("CODM") and how the CODM uses reported measures in assessing segment performance, and also extends the requirement of annual disclosures currently required by Topic 280 to interim periods. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is in the process of assessing the impact of adoption on its consolidated financial statements.

3. Revenue

The following table presents the Company’s disaggregated net sales by primary market served (dollars in thousands):

						Three months ended September 30,												Nine months ended September 30,
Customer Markets						2024						2023						2024						2023
Consumer Products						$	105,390					$	96,220					$	315,950					$	287,730
Aerospace & Defense						70,830						67,580						215,890						177,370
Industrial						53,140						71,540						165,120						218,890
Total net sales						$	229,360					$	235,340					$	696,960					$	683,990

The Company’s Packaging segment earns revenues from the consumer products (comprised of the beauty and personal care, food and beverage, home care, pharmaceutical, nutraceutical and medical submarkets) and industrial markets. The Aerospace segment earns revenues from the aerospace & defense market (comprised of commercial, regional and business jet, and military submarkets). The Specialty Products segment earns revenues from a variety of submarkets within the industrial market.

9

---

Table of Contents

TRIMAS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

4. Realignment Actions

2024 Realignment Actions

During the three and nine months ended September 30, 2024, the Company incurred pre-tax realignment charges of $0.9 million in its Packaging segment, related to the closure of its facility in Irwindale, California. For the three and nine months ended September 30, 2024, $0.5 million and $0.4 million of these charges were included in cost of sales and selling, general and administrative expenses, respectively, in the accompanying consolidated statement of income.

2023 Realignment Actions

During the nine months ended September 30, 2023, the Company incurred realignment charges in its Packaging segment, related to the closure and consolidation of two manufacturing facilities located in China into one new, larger facility in the Haining region, and for costs incurred to close and consolidate its Rohnert Park, California, manufacturing facility operations into other existing U.S. production locations. In connection with these actions, the Company recorded pre-tax realignment charges of $2.7 million and $6.4 million during the three and nine months ended September 30, 2023, respectively, of which $0.8 million and $2.1 million during the three and nine months ended September 30, 2023, respectively, were for employee-related costs, $0.8 million during the three and nine months ended September 30, 2023 was for inventory write-downs, $1.1 million and $1.3 million during the three and nine months ended September 30, 2023, respectively, were for other facility move and consolidation costs, and $2.2 million during the nine months ended September 30, 2023 was related to charges to accelerate the depreciation of certain fixed assets. For the three months ended September 30, 2023, $2.4 million and $0.3 million of these charges were included in cost of sales and selling, general and administrative expenses, respectively, in the accompanying consolidated statement of income. For the nine months ended September 30, 2023, $5.7 million and $0.7 million of these charges were included in cost of sales and selling, general and administrative expenses, respectively, in the accompanying consolidated statement of income.

5. Acquisitions

2023 Acquisitions

On April 21, 2023, the Company acquired Weldmac Manufacturing Company ("Weldmac") for a purchase price of $34.0 million, with additional contingent consideration ranging from zero to $10 million based on achievement of earnings targets, as defined in the purchase agreement. The fair value of assets acquired and liabilities assumed included $23.7 million of property and equipment, $20.3 million of net working capital and $10 million of contingent consideration liability, with such estimate representing the Company's best estimate of fair value of contingent consideration based on Level 3 inputs under the fair value hierarchy, as defined. Located in El Cajon, California, and reported in the Company's Aerospace segment, Weldmac is a designer and manufacturer of complex metal fabricated components and assemblies predominantly for the aerospace, defense and space launch end markets and historically generated $33 million in annual revenue. On July 10, 2023, the Company made a cash payment of $5.5 million as additional consideration for the purchase of Weldmac based on achievement of earnings targets, as defined in the purchase agreement. As of September 30, 2024, the remaining possible contingent consideration ranged from zero to $4.5 million, based on achievement of 2023 earnings targets. The calculation of 2023 earnings, as defined in the purchase agreement, was under review as of September 30, 2024. The Company expects to resolve the remaining contingent consideration matter in fourth quarter 2024. See Note 20, "Subsequent Events," for further details.

On February 1, 2023, the Company acquired Aarts Packaging B.V. ("Aarts"), a luxury packaging solutions provider for beauty and lifestyle brands, as well as for customers in the food and life sciences end markets, for a purchase price of $37.8 million, net of cash acquired. The fair value of assets acquired and liabilities assumed included $20.4 million of goodwill, $10.9 million of intangible assets, $8.5 million of property and equipment, $7.4 million of net working capital, $3.9 million of net deferred tax liabilities and $5.5 million of other liabilities. Aarts, which is reported in the Company's Packaging segment, is located in Waalwijk, The Netherlands, and historically generated €23 million in annual revenue.

10

---

Table of Contents

TRIMAS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

6. Goodwill and Other Intangible Assets

Goodwill

Changes in the carrying amount of goodwill for the nine months ended September 30, 2024 are summarized as follows (dollars in thousands):

			Packaging						Aerospace						Specialty Products						Total
Balance, December 31, 2023			$	287,350					$	69,860					$	6,560					$	363,770
Foreign currency translation and other			1,480						(150)						—						1,330
Balance, September 30, 2024			$	288,830					$	69,710					$	6,560					$	365,100

Other Intangible Assets

The Company amortizes its other intangible assets over periods ranging from one to 30 years. The gross carrying amounts and accumulated amortization of the Company's other intangibles are summarized below (dollars in thousands):

						As of September 30, 2024												As of December 31, 2023
Intangible Category by Useful Life						Gross Carrying Amount						Accumulated Amortization						Gross Carrying Amount						Accumulated Amortization
Finite-lived intangible assets:
Customer relationships, 5 – 12 years						$	141,540					$	(94,670)					$	141,260					$	(89,020)
Customer relationships, 15 – 25 years						129,670						(85,230)						129,830						(80,600)
Total customer relationships						271,210						(179,900)						271,090						(169,620)
Technology and other, 1 – 15 years						57,010						(43,990)						56,970						(41,850)
Technology and other, 17 – 30 years						43,300						(40,990)						43,300						(40,730)
Total technology and other						100,310						(84,980)						100,270						(82,580)
Indefinite-lived intangible assets:
Trademark/Trade names						62,010						—						61,860						—
Total other intangible assets						$	433,530					$	(264,880)					$	433,220					$	(252,200)

Amortization expense related to intangible assets as included in the accompanying consolidated statement of income is summarized as follows (dollars in thousands):

						Three months ended September 30,												Nine months ended September 30,
						2024						2023						2024						2023
Technology and other, included in cost of sales						$	810					$	800					$	2,470					$	2,410
Customer relationships, included in selling, general and administrative expenses						3,400						3,810						10,170						11,400
Total amortization expense						$	4,210					$	4,610					$	12,640					$	13,810

11

---

Table of Contents

TRIMAS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

7. Inventories

Inventories consist of the following components (dollars in thousands):

						September 30, 2024						December 31, 2023
Finished goods						$	90,010					$	82,300
Work in process						61,410						51,990
Raw materials						62,460						58,160
Total inventories						$	213,880					$	192,450

8. Property and Equipment, Net

Property and equipment consists of the following components (dollars in thousands):

						September 30, 2024						December 31, 2023
Land and land improvements						$	31,100					$	32,840
Buildings						95,550						99,230
Machinery and equipment						521,860						502,090
						648,510						634,160
Less: Accumulated depreciation						319,200						304,170
Property and equipment, net						$	329,310					$	329,990

Depreciation expense as included in the accompanying consolidated statement of income is as follows (dollars in thousands):

						Three months ended September 30,												Nine months ended September 30,
						2024						2023						2024						2023
Depreciation expense, included in cost of sales						$	9,660					$	9,080					$	29,150					$	29,150
Depreciation expense, included in selling, general and administrative expenses						280						210						790						680
Total depreciation expense						$	9,940					$	9,290					$	29,940					$	29,830

9. Long-term Debt

The Company's long-term debt consists of the following (dollars in thousands):

						September 30, 2024						December 31, 2023
4.125% Senior Notes due April 2029						$	400,000					$	400,000
Credit Agreement						13,500						—
Debt issuance costs						(3,630)						(4,340)
Long-term debt, net						$	409,870					$	395,660

Senior Notes

In March 2021, the Company issued $400.0 million aggregate principal amount of 4.125% senior notes due April 15, 2029 ("Senior Notes") at par value in a private placement under Rule 144A of the Securities Act of 1933, as amended ("Securities Act"). The Senior Notes accrue interest at a rate of 4.125% per annum, payable semi-annually in arrears on April 15 and October 15. The payment of principal and interest is jointly and severally guaranteed, on a senior unsecured basis, by certain subsidiaries of the Company. The Senior Notes are pari passu in right of payment with all existing and future senior indebtedness and effectively subordinated to all existing and future secured indebtedness to the extent of the value of the assets securing such indebtedness.

12

---

Table of Contents

TRIMAS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

The Company may redeem all or part of the Senior Notes at the redemption prices (expressed as percentages of principal amount) set forth below, plus accrued and unpaid interest, if any, to the redemption date, if redeemed during the twelve-month period beginning on April 15 of the years indicated below:

Year						Percentage
2024						102.063		%
2025						101.031		%
2026 and thereafter						100.000		%

Credit Agreement

The Company is a party to a credit agreement ("Credit Agreement") consisting of a $300.0 million senior secured revolving credit facility, which permits borrowings denominated in specific foreign currencies, subject to a $125.0 million sub limit, maturing on March 29, 2026. The Credit Agreement is subject to benchmark interest rates determined based on the currency denomination of borrowings, with British pound sterling borrowings subject to the Sterling Overnight Index Average and Euro borrowings to the Euro InterBank Offered Rate, both plus a spread of 1.75%, and U.S. dollar borrowings subject to the Secured Overnight Financing Rate plus a spread of 1.85%. The interest rate spread is based upon the leverage ratio, as defined, as of the most recent determination date. The Company's revolving credit facility allows for the issuance of letters of credit, not to exceed $40.0 million in aggregate.

The Credit Agreement also provides incremental revolving credit facility commitments in an amount not to exceed the greater of $200.0 million and an amount such that, after giving effect to such incremental commitments and the incurrence of any other indebtedness substantially simultaneously with the making of such commitments, the senior secured net leverage ratio, as defined, is no greater than 3.00 to 1.00. The terms and conditions of any incremental revolving credit facility commitments must be no more favorable than the existing credit facility.

At September 30, 2024, the Company had $13.5 million outstanding under its revolving credit facility and had $280.2 million potentially available after giving effect to $6.3 million of letters of credit issued and outstanding. At December 31, 2023, the Company had no amounts outstanding under its revolving credit facility and had $294.0 million potentially available after giving effect to $6.0 million of letters of credit issued and outstanding. After consideration of leverage restrictions contained in the Credit Agreement, as of September 30, 2024 and December 31, 2023, the Company had $183.3 million and $256.9 million, respectively, of borrowing capacity available for general corporate purposes.

The debt under the Credit Agreement is an obligation of the Company and certain of its domestic subsidiaries and is secured by substantially all of the assets of such parties. Borrowings under the $125.0 million (equivalent) foreign currency sub limit of the $300.0 million senior secured revolving credit facility are secured by a cross-guarantee amongst, and a pledge of the assets of, the foreign subsidiary borrowers that are a party to the agreement. The Credit Agreement also contains various negative and affirmative covenants and other requirements affecting the Company and its subsidiaries, including the ability, subject to certain exceptions and limitations, to incur debt, liens, mergers, investments, loans, advances, guarantee obligations, acquisitions, assets dispositions, sale-leaseback transactions, hedging agreements, dividends and other restricted payments, transactions with affiliates, restrictive agreements and amendments to charters, bylaws, and other material documents. The terms of the Credit Agreement also require the Company and its restricted subsidiaries to meet certain restrictive financial covenants and ratios computed quarterly, including a maximum total net leverage ratio (total consolidated indebtedness plus outstanding amounts under any accounts receivable securitization facility, less the aggregate amount of certain unrestricted cash and unrestricted permitted investments, as defined, over consolidated EBITDA, as defined), a maximum senior secured net leverage ratio (total consolidated senior secured indebtedness, less the aggregate amount of certain unrestricted cash and unrestricted permitted investments, as defined, over consolidated EBITDA, as defined) and a minimum interest expense coverage ratio (consolidated EBITDA, as defined, over the sum of consolidated cash interest expense, as defined, and preferred dividends, as defined). At September 30, 2024, the Company was in compliance with its financial covenants contained in the Credit Agreement.

13

---

Table of Contents

TRIMAS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

Other Revolving Loan Facility

In May 2021, the Company, through one of its non-U.S. subsidiaries, entered into a revolving loan facility with a borrowing capacity of $4 million. The facility is guaranteed by TriMas Corporation. At September 30, 2024, the Company had $0.1 million outstanding on this loan facility, which is included in short-term borrowings on the accompanying consolidated balance sheet. There were no borrowings outstanding on this loan facility as of December 31, 2023.

Fair Value of Debt

The valuations of the Senior Notes and revolving credit facility were determined based on Level 2 inputs under the fair value hierarchy, as defined. The carrying amounts and fair values were as follows (dollars in thousands):

						September 30, 2024												December 31, 2023
						Carrying Amount						Fair Value						Carrying Amount						Fair Value
4.125% Senior Notes due April 2029						$	400,000					$	379,500					$	400,000					$	364,000
Revolving credit facility						13,500						13,500						—						—

10. Derivative Instruments

Derivatives Designated as Hedging Instruments

The Company uses cross-currency swap contracts to hedge its net investment in Euro-denominated assets against future volatility in the exchange rate between the U.S. dollar and the Euro. By doing so, the Company synthetically converts a portion of its U.S. dollar-based long-term debt into Euro-denominated long-term debt.

In June 2024, the Company entered into a cross-currency swap agreement effective as of June 27, 2024, with a notional amount of $75.0 million and a contract period end date of October 15, 2027. Under the terms of the agreement, the Company is to receive net interest payments at a fixed rate of approximately 1.43% of the notional amount. At inception, the cross-currency swap was designated as a net investment hedge.

In February 2024, the Company entered into a cross-currency swap agreement effective as of April 15, 2024, with a notional amount of $75.0 million and a contract period end date of April 15, 2029. Under the terms of the agreement, the Company is to receive net interest payments at a fixed rate of approximately 1.06% of the notional amount. At inception, the cross-currency swap was designated as a net investment hedge. At designation, the cross currency swap had an inception date non-zero fair value equal to a $4.9 million liability, which offset the inception date non-zero fair value of a $75.0 million foreign currency exchange forward contract entered into on the same date. The non-zero fair value of the cross currency swap was recognized in other income (expense), net in the consolidated statement of income during the nine months ended September 30, 2024.

In February 2024, immediately prior to entering into the new cross-currency swap agreement, the Company voluntarily discontinued hedge accounting for its existing cross-currency swap agreement, de-designating the swap as a net investment hedge. The de-designated agreement had a notional amount of $75.0 million and a contract period end date of April 15, 2024. Under the terms of the agreement, the Company received net interest payments at a fixed rate of approximately 2.4% of the notional amount. At contract settlement, the cross currency swap agreement had a fair value equal to a $3.8 million liability, which was offset by the settlement of the $75.0 million foreign currency exchange forward contract that ended on the same date, both of which were classified as an investing activity in the accompanying consolidated statement of cash flows.

As of September 30, 2024 and December 31, 2023, the fair value carrying amount of the Company's derivatives designated as hedging instruments are recorded as follows (dollars in thousands):

Asset / (Liability) Derivatives

Derivatives Designated as Hedging Instruments

Balance Sheet Caption

September 30, 2024

December 31, 2023

Net Investment Hedges

Cross-currency swaps

Accrued liabilities

$

—

$

(6,510)

Cross-currency swaps

Other long-term liabilities

(10,300)

—

14

---

Table of Contents

TRIMAS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

The following table summarizes the income recognized in accumulated other comprehensive income (loss) ("AOCI") on derivative contracts designated as hedging instruments as of September 30, 2024 and December 31, 2023, and the amounts reclassified from AOCI into earnings for the nine months ended September 30, 2024 and 2023 (dollars in thousands):

			Amount of Income Recognized in AOCI on Derivatives (Effective Portion, net of tax)																		Amount of Income (Loss) Reclassified from AOCI into Earnings
			As of September 30, 2024						As of December 31, 2023						Location of Income (Loss) Reclassified from AOCI into Earnings (Effective Portion)						Three months ended September 30,												Nine months ended September 30,
																					2024						2023						2024						2023
Net Investment Hedges
Cross-currency swaps			$	10,620					$	13,260					Other income (expense), net						$	—					$	—					$	—					$	—

Over the next 12 months, the Company does not expect to reclassify any pre-tax deferred amounts from AOCI into earnings.

Derivatives Not Designated as Hedging Instruments

As of September 30, 2024, the Company was party to foreign currency exchange forward contracts to economically hedge changes in foreign currency rates with notional amounts of $141.9 million. The Company uses foreign exchange contracts to mitigate the risk associated with fluctuations in currency rates impacting cash flows related to certain of its receivables, payables and intercompany transactions denominated in foreign currencies. The foreign exchange contracts primarily mitigate currency exposures between the U.S. dollar and the Euro, Canadian dollar, Chinese yuan, and the Mexican peso, as well as between the Euro and British pound, and have various settlement dates through March 2025. These contracts are not designated as hedge instruments; therefore, gains and losses on these contracts are recognized each period directly into the consolidated statement of income.

The following table summarizes the effects of derivatives not designated as hedging instruments on the Company's consolidated statement of income (dollars in thousands):

												Amount of Income (Loss) Recognized in Earnings on Derivatives
												Three months ended September 30,												Nine months ended September 30,
						Location of Income (Loss) Recognized in Earnings on Derivatives						2024						2023						2024						2023
Derivatives not designated as hedging instruments
Foreign exchange contracts						Other income (expense), net						$	1,600					$	940					$	5,110					$	130
Cross-currency swaps						Other income (expense), net						—						—						810						—

15

---

Table of Contents

TRIMAS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

Fair Value of Derivatives

The fair value of the Company's derivatives are estimated using an income approach based on valuation techniques to convert future amounts to a single, discounted amount. Estimates of the fair value of the Company's cross-currency swaps and foreign exchange contracts use observable inputs such as interest rate yield curves and forward currency exchange rates. Fair value measurements and the fair value hierarchy level for the Company's assets and liabilities measured at fair value on a recurring basis as of September 30, 2024 and December 31, 2023 are shown below (dollars in thousands):  

Description						Frequency						Asset / (Liability)						Quoted Prices in Active Markets for Identical Assets (Level 1)						Significant Other Observable Inputs (Level 2)						Significant Unobservable Inputs (Level 3)
September 30, 2024
Cross-currency swaps						Recurring						$	(10,300)					$	—					$	(10,300)					$	—
Foreign exchange contracts						Recurring						$	1,170					$	—					$	1,170					$	—
December 31, 2023
Cross-currency swaps						Recurring						$	(6,510)					$	—					$	(6,510)					$	—
Foreign exchange contracts						Recurring						$	(140)					$	—					$	(140)					$	—

11. Leases

The majority of the Company's lease obligations are non-cancelable operating leases for certain equipment and facilities. The Company's finance leases are for certain equipment as part of the Company's acquisition of Aarts. Leases with an initial term of 12 months or less are not recorded on the balance sheet; expense related to these leases is recognized on a straight-line basis over the lease term.

Supplemental balance sheet information related to the Company's leases are shown below (dollars in thousands):

						Balance Sheet Location						September 30, 2024						December 31, 2023
Assets
Operating leases						Operating lease right-of-use assets						$	42,220					$	43,220
Finance leases						Property and equipment, net (a)						2,330						2,470
Total lease assets												$	44,550					$	45,690
Liabilities
Current:
Operating leases						Lease liabilities, current portion						$	7,410					$	7,410
Finance leases						Lease liabilities, current portion						490						490
Long-term:
Operating leases						Lease liabilities						37,280						37,980
Finance leases						Lease liabilities						1,370						1,710
Total lease liabilities												$	46,550					$	47,590

__________________________

(a)     Finance leases were recorded net of accumulated depreciation of $0.4 million and $0.2 million as of September 30, 2024 and December 31, 2023, respectively.

16

---

Table of Contents

TRIMAS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

The components of lease expense are as follows (dollars in thousands):

												Three months ended September 30,												Nine months ended September 30,
						Statement of Income Location						2024						2023						2024						2023
Operating lease cost						Cost of sales and Selling, general and administrative expenses						$	2,270					$	3,140					$	7,110					$	8,860
Finance lease cost:
Depreciation of lease assets						Cost of sales						70						50						180						150
Interest on lease liabilities						Interest expense						10						10						40						40
Short-term, variable and other lease costs						Cost of sales and Selling, general and administrative expenses						1,010						1,030						3,160						2,510
Total lease cost												$	3,360					$	4,230					$	10,490					$	11,560

Maturities of lease liabilities are as follows (dollars in thousands):

Year ended December 31,						Operating Leases(a)						Finance Leases(a)
2024 (excluding the nine months ended September 30, 2024)						$	2,270					$	150
2025						8,880						610
2026						9,120						700
2027						7,910						810
2028						6,470						—
Thereafter						17,180						—
Total lease payments						51,830						2,270
Less: Imputed interest						(7,140)						(410)
Present value of lease liabilities						$	44,690					$	1,860

__________________________

(a)     The maturity table excludes cash flows associated with exited lease facilities. Liabilities for exited lease facilities are included in accrued liabilities and other long-term liabilities in the accompanying consolidated balance sheet.

Other information related to the Company's leases are as follows (dollars in thousands):

						Three months ended September 30,												Nine months ended September 30,
						2024						2023						2024						2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases						$	2,360					$	2,540					$	7,040					$	7,760
Operating cash flows from finance leases						10						10						40						40
Financing cash flows from finance leases						120						120						360						320
Lease assets obtained in exchange for new lease liabilities:
Operating leases						4,170						3,560						5,120						8,340
Finance leases						—						—						—						2,620

The weighted-average remaining lease term of the Company's operating leases and finance leases as of September 30, 2024 is 6.37 years and 2.82 years, respectively. The weighted-average discount rate for the operating leases and finance leases as of September 30, 2024 is 4.2% and 2.6%, respectively.

17

---

Table of Contents

TRIMAS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

12. Other Long-term liabilities

Other long-term liabilities consist of the following components (dollars in thousands):

						September 30, 2024						December 31, 2023
Non-current asbestos-related liabilities						$	27,690					$	23,880
Other long-term liabilities						28,060						16,740
Total other long-term liabilities						$	55,750					$	40,620

13. Commitments and Contingencies

Asbestos

As of September 30, 2024, the Company was a party to 485 pending cases involving an aggregate of 4,907 claimants primarily alleging personal injury from exposure to asbestos containing materials formerly used in gaskets (both encapsulated and otherwise) manufactured or distributed by its former Lamons division and certain other related subsidiaries for use primarily in the petrochemical, refining and exploration industries. The following chart summarizes the number of claims, number of claims filed, number of claims dismissed, number of claims settled, the average settlement amount per claim and the total defense costs, at the applicable date and for the applicable periods:

						Claims pending at beginning of period						Claims filed during period						Claims dismissed during period						Claims settled during period						Claims pending at end of period						Average settlement amount per claim during period						Total defense costs during period
Nine Months Ended September 30, 2024						4,863						185						114						27						4,907						$	22,574					$	1,310,000
Fiscal Year Ended December 31, 2023						4,798						261						160						36						4,863						$	15,465					$	1,920,000

In addition, the Company acquired various companies to distribute its products that had distributed gaskets of other manufacturers prior to acquisition. The Company believes that many of its pending cases relate to locations at which none of its gaskets were distributed or used.

The Company may be subjected to significant additional asbestos-related claims in the future, and will aggressively defend or reasonably resolve, as appropriate. The cost of settling cases in which product identification can be made may increase, and the Company may be subjected to further claims in respect of the former activities of its acquired gasket distributors. The cost of claims varies as claims may be initially made in some jurisdictions without specifying the amount sought or by simply stating the requisite or maximum permissible monetary relief, and may be amended to alter the amount sought. The large majority of claims do not specify the amount sought. Of the 4,907 claims pending at September 30, 2024, 38 set forth specific amounts of damages (other than those stating the statutory minimum or maximum). At September 30, 2024, of the 38 claims that set forth specific amounts, there were no claims seeking more than $5 million for punitive damages. Below is a breakdown of the compensatory damages sought for those claims seeking specific amounts:

Compensatory

Range of damages sought (dollars in millions)

$0.0 to $0.6

$0.6 to $5.0

$5.0+

Number of claims

—

5

33

Relatively few claims have reached the discovery stage and even fewer claims have gone past the discovery stage. Total settlement costs (exclusive of defense costs) for all such cases, some of which were filed over 30 years ago, have been $13.7 million. All relief sought in the asbestos cases is monetary in nature. Based on the settlements made to date and the number of claims dismissed or withdrawn for lack of product identification, the Company believes that the relief sought (when specified) does not bear a reasonable relationship to its potential liability.

18

---

Table of Contents

TRIMAS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

The Company records a liability for asbestos-related claims, which includes both known and unknown claims, based on a study from the Company’s third-party actuary, the Company's review of the study, as well as the Company’s own review of asbestos claims and claim resolution activity.

In the third quarter of 2024, the Company commissioned its actuary to update the study, based on data as of May 31, 2024, which yielded a range of possible future liability of $31.0 million to $39.8 million, before consideration of any potential insurance recoveries. The Company did not believe any amount within the range of potential outcomes represented a better estimate than another given the many factors and assumptions inherent in the projections, and therefore recorded a pre-tax charge of $5.5 million to increase the liability estimate to $31.0 million, at the low-end of the range. The charge is included in selling, general and administrative expenses in the accompanying consolidated statement of income. As of September 30, 2024 and December 31, 2023, the Company’s total asbestos-related liability was $30.1 million and $26.6 million, respectively, and is included in accrued liabilities and other long-term liabilities in the accompanying consolidated balance sheet.

The Company’s primary insurance, which covered approximately 40% of historical costs related to settlement and defense of asbestos litigation, expired in November 2018, upon which the Company became solely responsible for defense costs and indemnity payments. The Company is party to a coverage-in-place agreement (entered into in 2006) with its first level excess carriers regarding the coverage to be provided to the Company for asbestos-related claims. The coverage-in-place agreement makes asbestos defense costs and indemnity insurance coverage available to the Company that might otherwise be disputed by the carriers and provides a methodology for the administration of such expenses. The Company will continue to be solely responsible for defense costs and indemnity payments prior to the commencement of coverage under this agreement, the duration of which would be subject to the scope of damage awards and settlements paid. Based upon the Company’s review of the most recent actuarial study, the Company believes it will reach the threshold of qualified future settlements required to commence excess carrier insurance coverage under the coverage-in-place agreement in 2025. As of September 30, 2024, the Company has not recognized an asbestos-related insurance recovery asset corresponding to its asbestos-related liability. The Company will continue to reassess its estimate of insurance recoveries and corresponding accounting for any such recoveries as the facts and circumstances change.

Based upon the Company's experience to date, including the trend in annual defense and settlement costs incurred to date, and other available information (including the availability of excess insurance), the Company does not believe these cases will have a material adverse effect on its financial position, results of operations, or cash flows.

Claims and Litigation

The Company is subject to other claims and litigation in the ordinary course of business, but does not believe that any such claim or litigation will have a material adverse effect on its financial position and results of operations or cash flows.

Environmental

The Company is responsible for environmental remediation at currently or previously owned facilities and waste sites, including sites defined under the Comprehensive Environmental Response, Compensation, and Liability Act, commonly referred to as “Superfund” for which the Company has been named a potential responsible party. During the three and nine months ended September 30, 2024, the Company recorded pre-tax charges of $1.8 million and $2.5 million, respectively, within selling, general and administrative expenses in the accompanying consolidated statement of income, bringing the Company’s environmental remediation obligation to $2.5 million as of September 30, 2024. The accrual is primarily based on environmental cost estimates provided by third parties and represents the best estimate of the Company’s proportionate share of costs to be incurred for site remediation efforts. Actual costs incurred resulting from the ultimate resolution of these uncertainties could exceed the amount accrued.

14. Segment Information

TriMas reports its operations in three segments: Packaging, Aerospace and Specialty Products. Each of these segments has discrete financial information that is regularly evaluated by TriMas' President and Chief Executive Officer (chief operating decision maker) in determining resource, personnel and capital allocation, as well as assessing strategy and performance. The Company utilizes its proprietary TriMas Business Model as its platform, which is based upon a standardized set of processes, to manage and drive results and strategy across its multi-industry businesses.

19

---

Table of Contents

TRIMAS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

Within each of the Company's reportable segments, there are no individual products or product families for which reported net sales accounted for more than 10% of the Company's consolidated net sales. See below for more information regarding the types of products and services provided within each reportable segment:

Packaging – TriMas' Packaging segment consists primarily of the Rieke, Affaba & Ferrari, Taplast, Rapak, Plastic Srl, Aarts Packaging, Intertech and Omega brands. TriMas Packaging develops and manufactures a broad array of dispensing products (such as foaming pumps, lotion, hand soap and sanitizer pumps, beverage dispensers, perfume sprayers, nasal sprayers and trigger sprayers), polymeric and steel caps and closures (such as food lids, flip-top closures, child resistant caps, beverage closures, fragrance and cosmetic caps, drum and pail closures, and flexible spouts), polymeric jar products, fully integrated dispensers for fill-ready bag-in-box applications, and consumable vascular delivery and diagnostic test components, all for a variety of consumer products submarkets including, but not limited to, beauty and personal care, food and beverage, home care, and life sciences, including but not limited to pharmaceutical, nutraceutical and medical, as well as industrial markets (including agricultural).

Aerospace – TriMas' Aerospace segment, which includes the Monogram Aerospace Fasteners, Allfast Fastening Systems, Mac Fasteners, TFI Aerospace, RSA Engineered Products, Martinic Engineering and Weldmac Manufacturing Company brands, develops, qualifies and manufactures highly-engineered, precision fasteners, tubular products and assemblies for fluid conveyance, and machined products and assemblies to serve the aerospace and defense market.

Specialty Products – TriMas' Specialty Products segment, which includes the Norris Cylinder and Arrow Engine brands, designs, manufactures and distributes highly-engineered steel cylinders for use within industrial and aerospace markets, natural gas-fired engines for remote power generation applications and compression systems for use within the North American industrial oil and gas and power generation end-markets.

Segment activity is as follows (dollars in thousands):

						Three months ended September 30,												Nine months ended September 30,
						2024						2023						2024						2023
Net Sales
Packaging						$	130,240					$	116,500					$	389,190					$	350,040
Aerospace						70,830						67,580						215,890						177,370
Specialty Products						28,290						51,260						91,880						156,580
Total						$	229,360					$	235,340					$	696,960					$	683,990
Operating Profit (Loss) and Income Before Income Tax Expense
Segment operating profit
Packaging						$	17,930					$	16,470					$	53,060					$	48,140
Aerospace						6,310						7,130						23,870						11,190
Specialty Products						2,290						10,510						5,480						32,360
Segment operating profit						26,530						34,110						82,410						91,690
Corporate (a)						(18,250)						(10,350)						(43,840)						(37,880)
Total operating profit						8,280						23,760						38,570						53,810
Interest expense						(4,860)						(3,950)						(15,010)						(11,620)
Other income (expense), net						(30)						(120)						(310)						(30)
Income before income tax expense						$	3,390					$	19,690					$	23,250					$	42,160

__________________________

(a)     Corporate consists of the corporate office and related corporate activities. Corporate expenses primarily include compensation, benefits, professional services, information technology and other administrative costs. Corporate expenses reconcile reportable segment information to the consolidated totals.

20

---

Table of Contents

TRIMAS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

15. Equity Awards

Restricted Stock Units

The Company awarded the following restricted stock units ("RSUs") during the nine months ended September 30, 2024:

•Granted 292,226 RSUs to certain employees, which are subject only to a service condition and vest ratably over three years so long as the employee remains with the Company;

•Granted 32,544 RSUs to its non-employee independent directors, which fully vest one year from date of grant so long as the director and/or Company does not terminate the director's service prior to the vesting date;

•Issued 93 RSUs to certain employees related to dividend equivalent rights on existing equity awards; and

•Issued 3,435 RSUs related to director fee deferrals as certain of the Company's directors elected to defer all or a portion of their director fees and to receive the amount in Company common stock at a future date.

During 2024, the Company also awarded 109,640 performance-based RSUs to certain Company key employees which vest three years from the grant date as long as the employee remains with the Company. These awards are initially earned 50% based upon the Company's achievement of an earnings per share compound annual growth rate ("EPS CAGR") metric and 50% based upon the Company's cash return on net assets ("Cash RONA") metric over a period beginning January 1, 2024 and ending December 31, 2026. The total EPS CAGR and Cash RONA performance-based RSUs initially earned shall be subject to modification based on the Company's total shareholder return ("TSR") relative to the TSR of the common stock of a pre-defined industry peer-group, measured over the performance period. TSR is calculated as the Company's average closing stock price for the 20 trading days at the end of the performance period plus Company dividends, divided by the Company's average closing stock price for the 20 trading days prior to the start of the performance period. The Company estimates the grant-date fair value subject to a market condition using a Monte Carlo simulation model, using the following weighted average assumptions: risk-free rate of 4.50% and annualized volatility of 31.4%. Depending on the performance achieved for these two metrics, the amount of shares earned, if any, can vary for each metric from 0% of the target award to a maximum of 250% of the target.

Information related to RSUs at September 30, 2024 is as follows:

						Number of Unvested RSUs						Weighted Average Grant Date Fair Value						Average Remaining Contractual Life (Years)						Aggregate Intrinsic Value
Outstanding at January 1, 2024						691,836						$	30.97
Granted						437,938						24.86
Vested						(196,088)						30.45
Cancelled						(91,656)						32.77
Outstanding at September 30, 2024						842,030						$	27.72					1.2						$	21,497,026

As of September 30, 2024, there was $6.4 million of unrecognized compensation cost related to unvested RSUs that is expected to be recorded over a weighted average period of 2.1 years.

RSUs granted to employees who are eligible for retirement on the date of the grant are expensed immediately, and RSUs granted to employees who will become retirement-eligible prior to the end of the vesting term are expensed over the period through which the employee will become retirement-eligible since these awards vest upon retirement from the Company. Compensation expense for RSUs granted to employees who will not become retirement-eligible prior to the end of the vesting term is recognized on a straight-line basis over the vesting period. The Company recognized stock-based compensation expense related to RSUs of $1.6 million and $3.1 million during the three months ended September 30, 2024 and 2023, respectively, and $8.1 million and $9.3 million during the nine months ended September 30, 2024 and 2023, respectively. The stock-based compensation expense is included in selling, general and administrative expenses in the accompanying consolidated statement of income.

21

---

Table of Contents

TRIMAS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

16. Earnings per Share

Net income is divided by the weighted average number of common shares outstanding during the period to calculate basic earnings per share. Diluted earnings per share is calculated to give effect to RSUs. The following table summarizes the dilutive effect of RSUs on common stock for the three and nine months ended September 30, 2024 and 2023:

						Three months ended September 30,												Nine months ended September 30,
						2024						2023						2024						2023
Weighted average common shares—basic						40,612,413						41,425,208						40,776,583						41,477,095
Dilutive effect of restricted stock units						334,158						248,173						312,625						229,772
Weighted average common shares—diluted						40,946,571						41,673,381						41,089,208						41,706,867

In March 2020, the Company announced its Board of Directors had authorized the Company to increase the purchase of its common stock up to $250 million in the aggregate. In the three and nine months ended September 30, 2024, the Company purchased 99,130 and 771,067 shares of its outstanding common stock for $2.4 million and $19.3 million, respectively. During the three and nine months ended September 30, 2023, the Company purchased 10,506 and 462,388 shares of its outstanding common stock for $0.3 million and $13.4 million, respectively. As of September 30, 2024, the Company had $67.6 million remaining under the repurchase authorization.

Holders of common stock are entitled to dividends at the discretion of the Company's Board of Directors. In 2021, the Company's Board of Directors declared the first dividend since the Company's initial public offering in 2007. During the three and nine months ended September 30, 2024, the Company's cash dividends declared were $0.04 per share of common stock and total dividends declared and paid on common shares were $1.7 million and $5.0 million, respectively. In the three and nine months ended September 30, 2023, the Company's cash dividends declared were $0.04 per share of common stock and total dividends declared and paid on common shares were $1.7 million and $5.0 million, respectively.

17. Defined Benefit Plans

Net periodic pension benefit costs for the Company's defined benefit pension plans cover certain foreign employees, union hourly employees and salaried employees. The components of net periodic pension cost (income) are as follows (dollars in thousands):

						Three months ended September 30,												Nine months ended September 30,
						2024						2023						2024						2023
Service costs						$	140					$	120					$	400					$	360
Interest costs						320						320						980						950
Expected return on plan assets						(510)						(530)						(1,530)						(1,580)
Settlement and curtailment losses						—						—						—						1,020
Amortization of net loss						50						20						140						90
Net periodic benefit cost (income)						$	—					$	(70)					$	(10)					$	840

The service cost component of net periodic benefit cost is recorded in cost of goods sold and selling, general and administrative expenses, while non-service cost components are recorded in other income (expense), net in the accompanying consolidated statement of income.

During the nine months ended September 30, 2023, the Company recognized a one-time, pre-tax settlement charge of $1.0 million related to the purchase of an annuity contract to transfer the Company's Canadian defined benefit obligations to an insurance company.

The Company contributed $0.5 million and $1.0 million to its defined benefit pension plans during the three and nine months ended September 30, 2024, respectively. The Company expects to contribute $1.2 million to its defined benefit pension plans for the full year 2024.

22

---

Table of Contents

TRIMAS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

18. Other Comprehensive Income (Loss)

Changes in AOCI by component for the nine months ended September 30, 2024 are summarized as follows, net of tax (dollars in thousands):

						Defined Benefit Plans						Derivative Instruments						Foreign Currency Translation						Total
Balance, December 31, 2023						$	(5,730)					$	13,260					$	(6,880)					$	650
Net unrealized gains (losses) arising during the period (a)						—						(2,640)						1,560						(1,080)
Less: Net realized losses reclassified to net income						(90)						—						—						(90)
Net current-period other comprehensive income (loss)						90						(2,640)						1,560						(990)
Balance, September 30, 2024						$	(5,640)					$	10,620					$	(5,320)					$	(340)

__________________________

(a)     Derivative instruments, net of income tax of $0.8 million. See Note 10, "Derivative Instruments," for further details.

Changes in AOCI by component for the nine months ended September 30, 2023 are summarized as follows, net of tax (dollars in thousands):

						Defined Benefit Plans						Derivative Instruments						Foreign Currency Translation						Total
Balance, December 31, 2022						$	(5,380)					$	15,320					$	(18,560)					$	(8,620)
Net unrealized gains arising during the period (a)						—						630						1,060						1,690
Less: Net realized losses reclassified to net income (b)						(780)						—						—						(780)
Net current-period other comprehensive income						780						630						1,060						2,470
Balance, September 30, 2023						$	(4,600)					$	15,950					$	(17,500)					$	(6,150)

__________________________

(a)     Derivative instruments, net of income tax of $0.2 million. See Note 10, "Derivative Instruments," for further details.

(b)     Defined benefit plans, net of income tax of $0.3 million. See Note 17, "Defined Benefit Plans," for further details.

19. Income Taxes

The effective income tax rate for the three months ended September 30, 2024 and 2023 was 25.4% and 16.3%, respectively. The Company recorded income tax expense of $0.9 million and $3.2 million for the three months ended September 30, 2024 and 2023, respectively. The effective tax rate for the three months ended September 30, 2024 was higher than in the prior year period primarily due to the recognition of approximately $2.4 million of tax benefit related to foreign tax loss carryforwards in the prior year period.

The effective income tax rate for the nine months ended September 30, 2024 and 2023 was 20.0% and 23.1%, respectively. The Company recorded income tax expense of $4.6 million and $9.7 million for the nine months ended September 30, 2024 and 2023, respectively, including tax benefits related to foreign tax loss carryforwards of $1.7 million and $2.4 million for the nine months ended September 30, 2024 and 2023, respectively. The effective tax rate for the nine months ended September 30, 2024 was lower than in the prior year period primarily due to a decrease in losses in jurisdictions where no tax benefit can be recorded, and the recognition of tax benefits related to foreign tax loss carryforwards. While the recorded tax benefit related to foreign tax loss carryforwards decreased compared to the prior year period, the impact on the effective tax rate increased due to a reduction in pre-tax income.

23

---

Table of Contents

TRIMAS CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

20. Subsequent Events

On October 25, 2024, the Company reached an agreement with the Weldmac sellers to pay $2.25 million as final contingent consideration for the Weldmac acquisition. The Company will make the cash payment and recognize the transaction in the fourth quarter of 2024.

On October 22, 2024, the Company announced that its Board of Directors had declared a cash dividend of $0.04 per share of TriMas Corporation common stock, which will be payable on November 12, 2024 to shareholders of record as of the close of business on November 5, 2024.

24

---

Table of Contents

Item 2.    Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition contains forward-looking statements regarding industry outlook and our expectations regarding the performance of our business. These forward-looking statements are subject to numerous risks and uncertainties, including, but not limited to, the risks and uncertainties described under the heading "Forward-Looking Statements," at the beginning of this report. Our actual results may differ materially from those contained in or implied by any forward-looking statements. You should read the following discussion together with the Company's reports on file with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2023.

Introduction

TriMas designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense and industrial markets through its TriMas Packaging, TriMas Aerospace and Specialty Products groups. Our wide range of innovative products are designed and engineered to solve application-specific challenges that our customers face. We believe our businesses share important and distinguishing characteristics, including: well-recognized and leading brand names in the markets we serve; innovative product technologies and features; a high-degree of customer approved processes and qualifications; established distribution networks; modest capital investment requirements; strong cash flow conversion and long-term growth opportunities. While the majority of our revenue is in the United States, we manufacture and supply products globally to a wide range of companies. We report our business activity in three segments: Packaging, Aerospace and Specialty Products.

Key Factors Affecting Our Reported Results  

Demand for the products our businesses produce and results of operations depend upon general economic conditions. We serve customers in industries that are highly competitive, and that may be significantly impacted by changes in economic or geopolitical conditions.

Our results of operations have been materially impacted over the past few years by macro-economic factors, first by the onset and proliferation of the coronavirus pandemic ("pandemic"), then further from increased energy costs and supply chain disruptions from the Russia-Ukraine conflict, and more recently by cost inflation (raw materials, wage rates and freight) and a lack of material and in certain regions skilled labor availability. These factors significantly affected each of our businesses and how we operate, albeit in different ways and magnitudes. Sales in our Packaging segment for dispensing and closure products used in applications to help fight the spread of germs have experienced extreme volatility in demand, with demand spiking to record highs after the onset of the pandemic, demand abating as expected from those high levels beginning mid-2022 and continuing through most of 2023, as a result of some of our larger customers' choices to rebalance on-hand inventory levels and caution in purchasing behaviors given the current inflationary macro-economic environment. Sales of certain of our aerospace-related products were significantly depressed from historical levels following the onset of the pandemic, but demand has significantly increased in recent quarters as air travel has picked up and new aircraft build rates improve. Certain of our products for industrial applications, for example steel cylinders for packaged gas applications, and engines and compressors for oil & gas extraction, have experienced volatility in demand related to a number of channel and economic factors in more recent periods. Altogether, this significant level of volatility in demand levels, input and transportation costs, and material and labor availability, have pressured our ability to operate efficiently in recent periods. While some areas of demand volatility remain, such as in our Specialty Products segment, we are beginning to see more steady and consistent demand in our Packaging and Aerospace end markets.

Overall, our third quarter 2024 net sales decreased $6.0 million, or 2.5%, compared to third quarter 2023. We experienced organic growth of 12.3% and 4.8% within our Packaging and Aerospace segments, respectively, compared to third quarter 2023. These increases were partially offset by lower sales of 44.8% in our Specialty Products segment as compared to the prior year quarter as we work through a cyclical demand trough.

The most significant drivers affecting our financial results in third quarter 2024 compared with third quarter 2023, other than as directly impacted by sales changes, were increased costs and decreased sales resulting from a prolonged labor union strike at one of our manufacturing facilities within our Aerospace segment, a charge to update our asbestos liability based on our recent actuarial valuation, improved material availability within our Aerospace segment, a charge associated with environmental remediation liabilities for a waste disposal service provider to one of our former operations, and an increase in our effective tax rate.

25

---

Table of Contents

In August 2024, our labor agreement with the United Automobile, Aerospace and Agricultural Implement Workers of America (UAW) at our TriMas Aerospace facility in Commerce, California, expired. On August 4, 2024, the UAW initiated a strike, causing a work stoppage that resulted in lost production volumes, reduced sales, manufacturing inefficiencies and $2.3 million increased costs through the end of third quarter 2024, with the Company and the UAW reaching a new labor agreement in mid-October 2024.

In third quarter 2024, we commissioned our actuary to update our asbestos study, and upon completion we recorded a pre-tax charge of $5.5 million, which is included in selling, general and administrative expenses.

In third quarter 2024, we recorded a pre-tax charge of $1.8 million for environmental remediation for a waste site in which we had been named a potential responsible party. The waste site related to a waste disposal service provider to one of our former operations.

The effective income tax rate for third quarter 2024 was 25.4% as compared to 16.3% for third quarter 2023. The effective tax rate for third quarter 2024 was higher than in the prior year primarily due to the recognition of approximately $2.4 million of tax benefit related to foreign tax loss carryforwards in the prior year period.

On a year-to-date basis, the following acquisitions were additional drivers of change in our year-over-year results of operations.

In April 2023, we acquired Weldmac Manufacturing Company ("Weldmac"), a designer and manufacturer of complex metal fabricated components and assemblies for the aerospace, defense and space launch end markets for a purchase price of $34.0 million, with additional consideration of $5.5 million paid in July 2023 and remaining contingent consideration ranging from zero to $4.5 million. The Company expects to resolve the remaining contingent consideration matter in fourth quarter 2024. Weldmac, which is reported in our Aerospace segment, is located in El Cajon, California. Weldmac contributed $12.9 million of acquisition-related net sales growth during the nine months ended September 30, 2024.

In February 2023, we acquired Aarts Packaging B.V. ("Aarts"), a luxury packaging solutions provider for beauty and lifestyle brands, as well as for customers in the food and life sciences end markets, for a purchase price of $37.8 million, net of cash acquired. Aarts, which is reported in our Packaging segment, is located in Waalwijk, the Netherlands and contributed $2.8 million of acquisition-related sales growth during the nine months ended September 30, 2024 resulting from its January 2024 sales.

Additional Key Risks that May Affect Our Reported Results

We have executed meaningful realignment actions over the past few years to address variable and structural costs where demand has fallen. We will continue to assess and take further actions if required. However, as a result of the current period of macroeconomic inflation and uncertainty and the potential impact of such factors to our future results of operations, as well as if there is an impact to TriMas' overall performance and market capitalization, we may record additional cash and non-cash charges related to further realignment actions, asset impairments, including impairments to our goodwill, intangible assets, fixed assets, inventory or customer receivable account balances.

Despite the potential for declines in future demand levels and results of operations, at present, we believe our capital structure is in a strong position. We have sufficient cash and available liquidity under our revolving credit facility to meet our debt service obligations, capital expenditure requirements and other short-term and long-term obligations for the foreseeable future.

Critical factors affecting our ability to succeed include: our ability to generate organic growth through product development, cross-selling and extending product-line offerings, and our ability to quickly and cost-effectively introduce and successfully launch new products; our ability to acquire and integrate companies or products that supplement existing product lines, add adjacent distribution channels and new customers, or expand our geographic coverage; our ability to manage our cost structure more efficiently via supply chain management, internal sourcing and/or purchasing of materials, selective outsourcing and/or purchasing of support functions, working capital management, and greater leverage of our administrative functions; and our ability to absorb, or recover via commercial actions, inflationary or other cost increases.

Our overall business does not experience significant seasonal fluctuation, other than our fourth quarter, which has tended to be the lowest net sales quarter of the year due to holiday shutdowns at certain customers or other customers deferring capital spending to the following year. A growing amount of our sales is derived from international sources, which exposes us to certain risks, including currency risks.

26

---

Table of Contents

We are sensitive to price movements and availability of our raw materials supply. Our largest raw material purchases are for polypropylene, polyethylene, steel, aluminum, superalloys (such as titanium, A286 stainless steel and Inconel) and other oil and metal-based purchased components, the costs for each of which are subject to volatility. There has also been some volatility over the past two years as a direct and indirect result of foreign trade policy, where tariffs on certain of our commodity-based products sourced from Asia have been instituted, the conflict in Eastern Europe, creating certain input material shortages, and labor shortages at certain of our raw material suppliers. We will continue to take actions to mitigate such increases, including implementing commercial pricing adjustments, holding extra inventories and resourcing to alternate suppliers and insourcing of previously sourced products. Although we believe we are generally able to mitigate the impact of higher commodity costs over time, we may experience additional material costs and disruptions in supply in the future and may not be able to pass along higher costs to our customers in the form of price increases or otherwise mitigate the impacts to our operating results.

Although we have escalator/de-escalator clauses in commercial contracts with certain of our customers to address fluctuations in input costs, or can modify prices based on market conditions to recover higher costs, our price increases generally lag the underlying input cost increase, and we cannot be assured of full cost recovery in the open market. If input costs increase at rapid rates, our ability to recover cost increases on a timely basis is made more difficult by the lag nature of these contracts.

Oil-based commodity costs are a significant driver of raw materials and purchased components used within our Packaging segment. As such, an increase in crude oil or natural gas often is a precursor to rising input polymeric raw material costs, for which we may experience a contractual commercial recovery lag. Separately, our Arrow Engine business in our Specialty Products segment is sensitive to the demand for natural gas and crude oil predominantly in the United States. For example, demand for engine, pump jack and compressor products are impacted by active oil and gas rig counts and wellhead investment activities.

Each year, as a core tenet of the TriMas Business Model, our businesses target cost savings from Kaizen (continuous improvement) initiatives in an effort to reduce, or otherwise offset, the impact of increased input and conversion costs through increased throughput and yield rates, with a goal of at least covering inflationary and market cost increases. In addition, we continuously review our operating cost structures to ensure alignment with current market demand.

We continue to evaluate alternatives to redeploy the cash generated by our businesses, one of which includes returning capital to our shareholders. In 2020, our Board of Directors increased the authorization of share repurchases to a cumulative amount of $250 million. During third quarter 2024, we purchased 99,130 shares of our outstanding common stock for an aggregate purchase price of $2.4 million. As of September 30, 2024, we had $67.6 million remaining under the repurchase authorization.

In addition, in third quarter 2024, we declared dividends of $0.04 per share of common stock and paid dividends of $1.7 million. We will continue to evaluate opportunities to return capital to shareholders through the purchase of our common stock, as well as dividends, depending on market conditions and other factors.

27

---

Table of Contents

Segment Information and Supplemental Analysis

The following table summarizes financial information for our reportable segments for the three months ended September 30, 2024 and 2023 (dollars in thousands):

			Three months ended September 30,
			2024						As a Percentage of Net Sales						2023						As a Percentage of Net Sales
Net Sales
Packaging			$	130,240					56.8		%				$	116,500					49.5		%
Aerospace			70,830						30.9		%				67,580						28.7		%
Specialty Products			28,290						12.3		%				51,260						21.8		%
Total			$	229,360					100.0		%				$	235,340					100.0		%
Gross Profit
Packaging			$	31,000					23.8		%				$	28,330					24.3		%
Aerospace			16,480						23.3		%				14,980						22.2		%
Specialty Products			4,220						14.9		%				12,620						24.6		%
Total			$	51,700					22.5		%				$	55,930					23.8		%
Selling, General and Administrative Expenses
Packaging			$	14,190					10.9		%				$	11,980					10.3		%
Aerospace			10,180						14.4		%				7,850						11.6		%
Specialty Products			1,840						6.5		%				2,110						4.1		%
Corporate			18,250						N/A						10,350						N/A
Total			$	44,460					19.4		%				$	32,290					13.7		%
Operating Profit (Loss)
Packaging			$	17,930					13.8		%				$	16,470					14.1		%
Aerospace			6,310						8.9		%				7,130						10.6		%
Specialty Products			2,290						8.1		%				10,510						20.5		%
Corporate			(18,250)						N/A						(10,350)						N/A
Total			$	8,280					3.6		%				$	23,760					10.1		%
Depreciation
Packaging			$	7,000					5.4		%				$	6,530					5.6		%
Aerospace			1,890						2.7		%				1,820						2.7		%
Specialty Products			1,000						3.5		%				900						1.8		%
Corporate			50						N/A						40						N/A
Total			$	9,940					4.3		%				$	9,290					3.9		%
Amortization
Packaging			$	1,640					1.3		%				$	1,630					1.4		%
Aerospace			2,570						3.6		%				2,870						4.2		%
Specialty Products			—						—		%				110						0.2		%
Corporate			—						N/A						—						N/A
Total			$	4,210					1.8		%				$	4,610					2.0		%

The following table summarizes detail on the year-over-year sales growth percentages for our reportable segments for the three months ended September 30, 2024 as compared to the three months ended September 30, 2023:

						Third Quarter 2024 vs. Third Quarter 2023
						Organic						Acquisitions						Foreign Exchange						Total
Consolidated TriMas Corporation						(2.3)		%				—		%				(0.2)		%				(2.5)		%
Packaging						12.3		%				—		%				(0.5)		%				11.8		%
Aerospace						4.8		%				—		%				—		%				4.8		%
Specialty Products						(44.8)		%				—		%				—		%				(44.8)		%

28

---

Table of Contents

The following table summarizes financial information for our reportable segments for the nine months ended September 30, 2024 and 2023 (dollars in thousands):

			Nine months ended September 30,
			2024						As a Percentage of Net Sales						2023						As a Percentage of Net Sales
Net Sales
Packaging			$	389,190					55.8		%				$	350,040					51.2		%
Aerospace			215,890						31.0		%				177,370						25.9		%
Specialty Products			91,880						13.2		%				156,580						22.9		%
Total			$	696,960					100.0		%				$	683,990					100.0		%
Gross Profit
Packaging			$	95,370					24.5		%				$	84,690					24.2		%
Aerospace			51,340						23.8		%				34,480						19.4		%
Specialty Products			11,710						12.7		%				38,980						24.9		%
Total			$	158,420					22.7		%				$	158,150					23.1		%
Selling, General and Administrative Expenses
Packaging			$	43,430					11.2		%				$	36,640					10.5		%
Aerospace			27,480						12.7		%				23,290						13.1		%
Specialty Products			6,140						6.7		%				6,600						4.2		%
Corporate			43,840						N/A						37,880						N/A
Total			$	120,890					17.3		%				$	104,410					15.3		%
Operating Profit (Loss)
Packaging			$	53,060					13.6		%				$	48,140					13.8		%
Aerospace			23,870						11.1		%				11,190						6.3		%
Specialty Products			5,480						6.0		%				32,360						20.7		%
Corporate			(43,840)						N/A						(37,880)						N/A
Total			$	38,570					5.5		%				$	53,810					7.9		%
Depreciation
Packaging			$	20,820					5.3		%				$	21,190					6.1		%
Aerospace			5,900						2.7		%				5,770						3.3		%
Specialty Products			3,080						3.4		%				2,770						1.8		%
Corporate			140						N/A						100						N/A
Total			$	29,940					4.3		%				$	29,830					4.4		%
Amortization
Packaging			$	4,930					1.3		%				$	4,810					1.4		%
Aerospace			7,710						3.6		%				8,660						4.9		%
Specialty Products			—						—		%				340						0.2		%
Corporate			—						N/A						—						N/A
Total			$	12,640					1.8		%				$	13,810					2.0		%

The following table summarizes detail on the year-over-year sales growth percentages for our reportable segments for the nine months ended September 30, 2024 as compared to the nine months ended September 30, 2023:

						Year to Date Third Quarter 2024 vs. Year to Date Third Quarter 2023
						Organic						Acquisitions						Foreign Exchange						Total
Consolidated TriMas Corporation						(0.3)		%				2.3		%				(0.1)		%				1.9		%
Packaging						10.5		%				0.8		%				(0.1)		%				11.2		%
Aerospace						14.4		%				7.3		%				—		%				21.7		%
Specialty Products						(41.3)		%				—		%				—		%				(41.3)		%

29

---

Table of Contents

Results of Operations

The principal factors impacting us during the three months ended September 30, 2024, compared with the three months ended September 30, 2023, were:

•Increases in demand for products within our Packaging and Aerospace segments;

•Significant demand decrease in our Specialty Products segment;

•Increased costs, decreased sales levels and manufacturing inefficiencies resulting from a prolonged labor union strike at one of our manufacturing facilities in our Aerospace segment;

•Expenses associated with our asbestos exposure to update the liability to recent actuarial studies;

•Improved material availability and resulting production efficiencies in our Aerospace segment;

•Environmental remediation expenses related to a waste disposal service provider to one of our former operations; and

•An increase in our effective tax rate in third quarter 2024 compared with third quarter 2023.

Three Months Ended September 30, 2024 Compared with Three Months Ended September 30, 2023

Overall, net sales decreased $6.0 million, or 2.5%, to $229.4 million for the three months ended September 30, 2024, as compared with $235.3 million in the three months ended September 30, 2023. Organic sales, excluding the impact of currency exchange, decreased $5.4 million, or 2.3%, as organic sales increases of 12.3% and 4.8% within our Packaging and Aerospace segments, respectively, were more than offset by a 44.8% sales decrease in our Specialty Products segment. In addition, net sales decreased by $0.6 million due to currency exchange, as our reported results in U.S. dollars were unfavorably impacted as a result of the strengthening of the U.S. dollar relative to foreign currencies.

Gross profit margin (gross profit as a percentage of sales) approximated 22.5% and 23.8% for the three months ended September 30, 2024 and 2023, respectively. Gross profit margin decreased primarily due to lower sales compared to third quarter of 2023 and related less favorable leveraging of fixed costs within our Specialty Products segment, and increased input costs, production inefficiencies and higher costs related to high demand for certain product lines in our Packaging segment, as well as increased costs and manufacturing inefficiencies resulting from the labor union strike within our Aerospace segment. These decreases were partially offset by higher sales levels, the favorable impact of prior year cost reduction efforts and $1.9 million of lower realignment costs within our Packaging segment. In addition, gross profit increased due to improved fixed costs absorption, reduced material availability constraints, a more favorable product sales mix, favorable commercial recoveries and a non-cash charge related to Weldmac purchase accounting of $1.2 million in third quarter of 2023 that did not repeat within our Aerospace segment.

Operating profit margin (operating profit as a percentage of sales) approximated 3.6% and 10.1% for the three months ended September 30, 2024 and 2023, respectively. Operating profit decreased $15.5 million to $8.3 million in the three months ended September 30, 2024, from $23.8 million for the three months ended September 30, 2023, primarily due to lower sales levels and less favorable leveraging of fixed costs within our Specialty Products segment, $5.5 million of pre-tax charges related to updating our asbestos studies in third quarter 2024 and $1.8 million of pre-tax charges related to our environment remediation obligations. Additionally, operating profit decreased due to increased input costs, production inefficiencies and higher costs related to high demand for certain product lines in our Packaging segment, as well as increased costs and manufacturing inefficiencies resulting from the labor union strike within our Aerospace segment. The decreases were partially offset by higher sales levels, lower realignment costs and the impact of $1.0 million higher net gains on sales of non-core properties within the Packaging segment, as well as reduced material availability constraints, a more favorable product sales mix, favorable commercial recoveries and a non-cash charge related to Weldmac purchase accounting in third quarter of 2023 that did not repeat within the Aerospace segment.

Interest expense increased $0.9 million, to $4.9 million for the three months ended September 30, 2024, compared to $4.0 million for the three months ended September 30, 2023, due to an increase in our weighted average borrowings and a higher effective interest rate as a result of increased borrowings from our revolving credit facility.

Other income (expense) decreased $0.1 million to a nominal amount of expense for the three months ended September 30, 2024, as compared to $0.1 million of expense for the three months ended September 30, 2023, primarily due to a decrease in losses on transactions denominated in foreign currencies.

30

---

Table of Contents

The effective income tax rate for the three months ended September 30, 2024 and 2023 was 25.4% and 16.3%, respectively. We recorded income tax expense of $0.9 million and $3.2 million for the three months ended September 30, 2024 and 2023, respectively. The effective tax rate for the three months ended September 30, 2024 was higher than in the prior year primarily due to the recognition of approximately $2.4 million of tax benefit related to foreign tax loss carryforwards in the prior year period.

Net income decreased $14.0 million, to $2.5 million for the three months ended September 30, 2024, as compared to $16.5 million for the three months ended September 30, 2023. The decrease was primarily the result of a decrease in operating profit of $15.5 million and an increase in interest expense of $0.9 million, partially offset by a decrease in income tax expense of $2.3 million and a decrease in other expense of $0.1 million.

See below for a discussion of operating results by segment.

Packaging. Net sales increased $13.7 million, or 11.8% (of which 12.3% was organic and (0.5)% was foreign currency exchange), to $130.2 million in the three months ended September 30, 2024, as compared to $116.5 million in the three months ended September 30, 2023. Sales of dispensing products used primarily for beauty, personal care and home care applications increased by $9.2 million. Sales of products used for industrial applications increased by $4.8 million. Sales of products used in food and beverage applications increased by $0.9 million. Net sales decreased by $0.6 million due to currency exchange, as our reported results in U.S. dollars were unfavorably impacted as a result of the strengthening of the U.S. dollar relative to foreign currencies, as compared to third quarter 2023.

Gross profit increased $2.7 million to $31.0 million, or 23.8% of sales, in the three months ended September 30, 2024, as compared to $28.3 million, or 24.3% of sales, in the three months ended September 30, 2023, primarily due to higher sales levels, the favorable impact of prior year cost reduction efforts, and the impact of $1.9 million lower realignment costs. Gross profit margin decreased due to increased input costs, production inefficiencies and increased costs related to high demand for certain product lines.

Selling, general and administrative expenses increased $2.2 million to $14.2 million, or 10.9% of sales, in the three months ended September 30, 2024, as compared to $12.0 million, or 10.3% of sales, in the three months ended September 30, 2023, primarily due to $1.2 million higher information technology costs allocated from Corporate and higher employee-related costs.

Operating profit increased $1.5 million to $17.9 million, or 13.8% of sales, in the three months ended September 30, 2024, as compared to $16.5 million, or 14.1% of sales, in the three months ended September 30, 2023, primarily due to higher sales volume and lower realignment costs and the impact of $1.0 million higher net gains on sale of non-core properties. Operating profit as a percentage of net sales decreased due to increased input costs, production inefficiencies, and higher selling, general and administrative expenses.

Aerospace.    Net sales for the three months ended September 30, 2024 increased $3.3 million, or 4.8%, to $70.8 million, as compared to $67.6 million in the three months ended September 30, 2023. Sales of our engineered components products increased by $3.1 million due to improved throughput. Sales of our fasteners products increased by $0.2 million as increases in aircraft build rates, improved production yield and commercial recoveries were mostly offset by a decrease in sales due to the labor union strike related to negotiations for a new three-year collective bargaining agreement at our Aerospace facility in Commerce, California.

Gross profit increased $1.5 million to $16.5 million, or 23.3% of sales, in the three months ended September 30, 2024, from $15.0 million, or 22.2% of sales, in the three months ended September 30, 2023. Gross profit increased primarily due to higher sales levels and resulting improved fixed cost absorption, reduced material availability constraints, a more favorable product sales mix, favorable commercial recoveries and a $1.2 million purchase accounting non-cash charge related to the step-up of Weldmac's inventory to fair value in third quarter of 2023 that did not repeat. These increases were partially offset by increased costs and manufacturing inefficiencies resulting from the labor union strike.

Selling, general and administrative expenses increased $2.3 million to $10.2 million, or 14.4% of sales, in the three months ended September 30, 2024, as compared to $7.9 million, or 11.6% of sales, in the three months ended September 30, 2023, primarily due to $1.3 million of increased costs related to the labor union strike, higher employee-related costs and higher information technology costs.

Operating profit decreased $0.8 million to $6.3 million, or 8.9% of sales, in the three months ended September 30, 2024, as compared to $7.1 million, or 10.6% of sales, in the three months ended September 30, 2023, as manufacturing inefficiencies and increased costs related to the strike and higher selling, general and administrative expenses more than offset higher sales levels, reduced material availability constraints, a more favorable product sales mix, favorable commercial recoveries and the impact of the purchase accounting adjustment related to Weldmac's inventory step-up to fair value in third quarter of 2023 that did not repeat.

31

---

Table of Contents

Specialty Products.   Net sales for the three months ended September 30, 2024 decreased $23.0 million, or 44.8%, to $28.3 million, as compared to $51.3 million in the three months ended September 30, 2023. Sales of our forged steel cylinders decreased $16.6 million, or 41.8%, due predominantly to lower demand for heating, ventilation, and air conditioning ("HVAC") applications as compared to the prior year quarter where a high rate of orders were placed by customers concerned with global supply of cylinders for HVAC applications. Sales of natural gas fired engines, compressors and related parts used in remote power generation and assistance applications for natural gas and crude oil extraction decreased by $6.4 million, or 55.1%, primarily as a result of lower compression package sales from a customer that has reduced their ordering rate significantly as compared to prior year quarter.

Gross profit decreased $8.4 million to $4.2 million, or 14.9% of sales, in the three months ended September 30, 2024, as compared to $12.6 million, or 24.6% of sales, in the three months ended September 30, 2023, primarily due to lower sales levels, which resulted in significantly less favorable absorption of fixed costs.

Selling, general and administrative expenses decreased $0.3 million to $1.8 million, or 6.5% of sales, in the three months ended September 30, 2024, as compared to $2.1 million, or 4.1% of sales, in the three months ended September 30, 2023, as $0.5 million of information technology costs allocated from Corporate was more than offset by reduced spending levels in third quarter of 2024, consistent with current lower demand levels.

Operating profit decreased $8.2 million to $2.3 million, or 8.1% of sales, in the three months ended September 30, 2024, as compared to $10.5 million, or 20.5% of sales, in the three months ended September 30, 2023, primarily due to lower sales levels, which resulted in significantly less favorable absorption of fixed costs.

Corporate.    Corporate expenses consist of the following (dollars in millions):

						Three months ended September 30,
						2024						2023
Corporate operating expenses						$	8.6					$	7.2
Non-cash stock compensation						1.6						3.1
Legacy expenses						8.1						0.1
Corporate expenses						$	18.3					$	10.4

Corporate expenses increased $7.9 million to $18.3 million for the three months ended September 30, 2024, from $10.4 million for the three months ended September 30, 2023, primarily due to a $5.5 million pre-tax charge related to updating our asbestos studies in the third quarter of 2024, $2.2 million of higher professional fees primarily for business diligence and strategic consulting, and a $1.8 million pre-tax charge for environmental remediation obligations related to a waste disposal service provider to one of our former operations. Information technology costs increased during the period by $0.1 million, as $2.3 million of technology costs allocated to our segments, which were not allocated in 2023, were offset by higher costs associated with the upgrade of certain key information technology applications. These increases were partially offset by a $1.5 million decrease in non-cash stock compensation due to timing and estimated attainment of existing awards.

Nine Months Ended September 30, 2024 Compared with Nine Months Ended September 30, 2023

Overall, net sales increased $13.0 million, or 1.9%, to $697.0 million for the nine months ended September 30, 2024, as compared with $684.0 million in the nine months ended September 30, 2023. Acquisition-related sales growth was $15.7 million, comprised of $2.8 million from our February 2023 acquisition of Aarts, and $12.9 million from our April 2023 acquisition of Weldmac. Organic sales, excluding the impact of currency exchange and acquisitions, decreased $2.4 million, or 0.3%, as organic sales increases of 10.5% and 14.4% within our Packaging and Aerospace segments, respectively, driven by end market demand improvements were more than offset by a 41.3% sales decrease in our Specialty Products segment due to lower market demand. In addition, net sales decreased by $0.3 million due to currency exchange, as our reported results in U.S. dollars were unfavorably impacted as a result of a strengthening U.S. dollar relative to foreign currencies.

32

---

Table of Contents

Gross profit margin (gross profit as a percentage of sales) approximated 22.7% for the nine months ended September 30, 2024 and 23.1% for the nine months ended September 30, 2023. Gross profit margin decreased primarily due to reduced sales and significantly less favorable absorption of fixed costs within our Specialty Products segment as well as increased input costs, the impact of a $2.6 million commercial settlement in 2023 that did not repeat in the first nine months of 2024, and higher production costs related to demand reversion above peak capacity for certain product lines in our Packaging segment. Also contributing to the decrease in gross profit were increased costs and manufacturing inefficiencies resulting from the labor union strike within our Aerospace segment. The decrease in gross profit was partially offset by higher sales levels and related improved fixed cost absorption and the impact of a non-cash charge related to purchase accounting in the first nine months of 2023 that did not repeat within our Packaging and Aerospace segments. Additionally, gross margin increased due to reduced material availability constraints, a more favorable product sales mix, and favorable commercial recoveries within our Aerospace segment, and the lower year-over-year impact of realignment costs within our Packaging segment.

Operating profit margin (operating profit as a percentage of sales) approximated 5.5% and 7.9% for the nine months ended September 30, 2024 and 2023, respectively. Operating profit decreased $15.2 million, to $38.6 million, for the nine months ended September 30, 2024, compared to $53.8 million for the nine months ended September 30, 2023, primarily due to decreased sales and significantly less favorable absorption of fixed costs within our Specialty Products segment, a $5.5 million pre-tax charge related to updating our asbestos studies in third quarter 2024, and $2.5 million of pre-tax charges related to our environmental remediation obligations. Additionally, operating profit decreased due to increased input costs and higher production costs related to high demand for certain product lines in our Packaging segment, as well as increased costs and manufacturing inefficiencies resulting from the labor union strike within our Aerospace segment. The decreases were partially offset by higher sales levels and related improved fixed cost absorption and the impact of a non-cash charge related to purchase accounting in the first nine months of 2023 that did not repeat within our Packaging and Aerospace segments. Operating profit further increased due to lower realignment costs and the impact of $1.0 million higher net gains on sales of non-core properties within the Packaging segment, as well as reduced material availability constraints, a more favorable product sales mix, and favorable commercial recoveries within the Aerospace segment.

Interest expense increased $3.4 million, to $15.0 million, for the nine months ended September 30, 2024, as compared to $11.6 million for the nine months ended September 30, 2023, due to an increase in our weighted average borrowings and a higher effective interest rate as a result of increased borrowings from our revolving credit facility.

Other income (expense) increased $0.3 million to $0.3 million of expense for the nine months ended September 30, 2024, as compared to a nominal amount of expense for the nine months ended September 30, 2023, primarily due to an increase in net losses on transactions denominated in foreign currencies, partially offset by a non-cash settlement charge for our Canadian defined benefit obligations during the nine months ended September 30, 2023.

The effective income tax rate for the nine months ended September 30, 2024 and 2023 was 20.0% and 23.1%, respectively. We recorded tax expense of $4.6 million for the nine months ended September 30, 2024, as compared to $9.7 million for the nine months ended September 30, 2023, including tax benefits related to foreign tax loss carryforwards of $1.7 million and $2.4 million for the nine months ended September 30, 2024 and 2023, respectively. The effective tax rate for the nine months ended September 30, 2024 is lower than in the prior year primarily due to a decrease in losses in jurisdictions where no tax benefit could be recorded and the recognition of tax benefits related to foreign tax loss carryforwards. While the recorded tax benefit related to foreign tax loss carryforwards decreased compared to the prior year period, the impact on the effective tax rate increased due to a reduction in pre-tax income.

Net income decreased by $13.8 million, to $18.6 million for the nine months ended September 30, 2024, compared to $32.4 million for the nine months ended September 30, 2023. The decrease was primarily the result of a decrease in operating profit of $15.2 million, increase in interest expense of $3.4 million, and increase in other expense of $0.3 million, partially offset by $5.1 million decrease in income tax expense.

See below for a discussion of operating results by segment.

33

---

Table of Contents

Packaging.   Net sales increased $39.2 million, or 11.2% (of which 10.5% was organic, 0.8% related to acquisitions, and (0.1)% was foreign currency exchange), to $389.2 million in the nine months ended September 30, 2024, as compared to $350.0 million in the nine months ended September 30, 2023. Acquisition-related sales growth was $2.8 million resulting from the January 2024 sales of our February 2023 acquisition of Aarts. Sales of dispensing products used primarily for beauty, personal care and home care applications increased by $26.6 million. Sales of products used for industrial applications increased by $11.0 million. Sales for life sciences, pharmaceutical and nutraceutical applications increased by $2.4 million. These increases were partially offset by the decrease in sales of products used in food and beverage applications of $2.6 million, primarily due to reduced demand for certain dairy applications in North America and beverage closure applications in Europe as certain customers prepare for cutting over to a new product design. Net sales decreased by $0.3 million due to currency exchange, as our reported results in U.S. dollars were unfavorably impacted as a result of the strengthening U.S. dollar relative to foreign currencies, as compared to 2023.

Gross profit increased $10.7 million to $95.4 million, or 24.5% of sales, in the nine months ended September 30, 2024, as compared to $84.7 million, or 24.2% of sales, in the nine months ended September 30, 2023, primarily due to higher sales levels and resulting improved fixed cost absorption, the favorable impact of prior year cost reduction efforts, and the impact of $5.2 million lower realignment costs and a $0.8 million purchase accounting non-cash charge related to the step-up of inventory to fair value in the first nine months of 2023 that did not repeat in the first nine months of 2024. The increase in gross profit was partially offset by a successful $2.6 million commercial settlement in 2023 that did not repeat, increased input costs, including expedited freight and labor, required to timely fulfill an abrupt increase in a customer's orders in 2024, and higher costs related to high demand for certain product lines.

Selling, general and administrative expenses increased $6.8 million to $43.4 million, or 11.2% of sales, in the nine months ended September 30, 2024, as compared to $36.6 million, or 10.5% of sales, in the nine months ended September 30, 2023, primarily due to $3.4 million higher information technology costs allocated from Corporate, higher employee-related costs and higher professional fees.

Operating profit increased $4.9 million to $53.1 million, or 13.6% of sales, in the nine months ended September 30, 2024, as compared to $48.1 million, or 13.8% of sales, in the nine months ended September 30, 2023, primarily due to higher sales levels, improved fixed cost absorption, and the favorable impact of prior realignment actions, and the impact of $1.0 million higher net gains on sale of non-core properties. These increases were partially offset by higher selling, general and administrative expenses, the impact of a successful commercial settlement in first nine months of 2023 that did not repeat, and increased input costs, including expedited freight to timely fulfill an abrupt increase in a customer's orders.

Aerospace.    Net sales for the nine months ended September 30, 2024 increased $38.5 million, or 21.7% (of which 14.4% was organic and 7.3% related to acquisitions), to $215.9 million, as compared to $177.4 million in the nine months ended September 30, 2023. Acquisition-related sales growth from our April 2023 acquisition of Weldmac was $12.9 million. Sales of our fasteners products increased by $16.0 million due to increases in aircraft build rates, improved production yield and commercial recoveries, partially offset by a decrease in sales due to the labor union strike related to negotiations for the renewal of the collective bargaining agreement at our Aerospace facility in Commerce, California. Sales of our engineered components products increased by $9.6 million due to improved throughput.

Gross profit increased $16.9 million to $51.3 million, or 23.8% of sales, in the nine months ended September 30, 2024, from $34.5 million, or 19.4% of sales, in the nine months ended September 30, 2023. Gross profit increased primarily due to higher sales levels and resulting improved fixed cost absorption, reduced material availability constraints, a more favorable product sales mix, favorable commercial recoveries, and a $2.0 million purchase accounting non-cash charge related to the step-up of inventory to fair value in 2023 that did not repeat. These increases were partially offset by increased costs and manufacturing inefficiencies resulting from the labor union strike.

Selling, general and administrative expenses increased $4.2 million to $27.5 million, or 12.7% of sales, in the nine months ended September 30, 2024, as compared to $23.3 million, or 13.1% of sales, in the nine months ended September 30, 2023, primarily due to higher employee-related costs, higher information technology costs, $1.3 million of increased costs related to the labor union strike, and higher ongoing selling, general and administrative costs associated with our acquisition of Weldmac. These increases were partially offset by lower legal costs and lower intangible asset amortization expense due to certain assets becoming fully amortized.

Operating profit increased $12.7 million to $23.9 million, or 11.1% of sales, in the nine months ended September 30, 2024, as compared to $11.2 million, or 6.3% of sales, in the nine months ended September 30, 2023, primarily due to the impact of higher sales levels, improved fixed cost absorption, reduced material availability production constraints, a more favorable product sales mix, commercial recoveries, and a purchase accounting adjustment related to Weldmac's inventory step-up to fair value in 2023 that did not repeat, partially offset by higher selling, general and administrative expenses and increased costs and manufacturing inefficiencies related to the strike.

34

---

Table of Contents

Specialty Products.    Net sales for the nine months ended September 30, 2024 decreased $64.7 million, or 41.3%, to $91.9 million, as compared to $156.6 million in the nine months ended September 30, 2023. Sales of forged steel cylinders decreased $43.6 million, or 36.4%, due predominantly to lower demand for HVAC applications as compared to the prior year where a high rate of orders were placed by customers concerned with global supply of steel cylinders for HVAC applications. Sales of natural gas fired engines, compressors and related parts used in remote power generation and assistance applications for natural gas and crude oil extraction decreased by $21.1 million, or 57.4%, primarily as a result of lower compression package sales from a customer that has reduced their ordering rate significantly as compared to the prior year.

Gross profit decreased $27.3 million to $11.7 million, or 12.7% of sales, in the nine months ended September 30, 2024, as compared to $39.0 million, or 24.9% of sales, in the nine months ended September 30, 2023, primarily due to lower sales levels, which resulted in significantly less favorable absorption of fixed costs.

Selling, general and administrative expenses decreased $0.5 million to $6.1 million, or 6.7% of sales, in the nine months ended September 30, 2024, as compared to $6.6 million, or 4.2% of sales, in the nine months ended September 30, 2023, as $1.3 million of higher information technology costs allocated from Corporate was more than offset by cost reduction actions in the first nine months of 2024, in response to lower market demand levels.

Operating profit decreased $26.9 million to $5.5 million, or 6.0% of sales, in the nine months ended September 30, 2024, as compared to $32.4 million, or 20.7% of sales, in the nine months ended September 30, 2023, primarily due to lower sales levels, which resulted in significantly less favorable absorption of fixed costs.

Corporate.    Corporate expenses, net consist of the following (dollars in millions):

						Nine months ended September 30,
						2024						2023
Corporate operating expenses						$	27.3					$	28.5
Non-cash stock compensation						8.1						9.3
Legacy expenses						8.4						0.1
Corporate expenses						$	43.8					$	37.9

Corporate expenses increased $6.0 million to $43.8 million for the nine months ended September 30, 2024, from $37.9 million for the nine months ended September 30, 2023, primarily due to a $5.5 million pre-tax charge related to updating our asbestos studies in the third quarter of 2024 and $2.5 million of pre-tax charges related to our environment remediation obligations. The increases were partially offset by a $1.3 million decrease in non-cash stock compensation due to timing and estimated attainment of existing awards, a $0.9 million decrease in professional fees as we incurred less costs for business strategy and other consulting services, and a $0.2 million decrease in technology costs, as $6.7 million of technology costs allocated to our segments was mostly offset by $6.5 million higher costs in preparation for upgrades in certain of our information technology application.

35

---

Table of Contents

Liquidity and Capital Resources

Cash Flows

Cash flows provided by operating activities were $36.7 million for the nine months ended September 30, 2024, as compared to cash provided of $57.6 million for the nine months ended September 30, 2023. Significant changes in cash flows provided by operating activities and the reasons for such changes were as follows:

•For the nine months ended September 30, 2024, we generated $87.3 million in cash flows, based on net income of $18.6 million and after considering the effects of non-cash items related to depreciation, amortization, and gain on dispositions of assets, changes in deferred income taxes, stock-based compensation, provision for losses on accounts receivable, changes in asbestos and environmental liability estimates, and other operating activities. For the nine months ended September 30, 2023, we generated $89.4 million in cash flows based on net income of $32.4 million and after considering the effects of similar non-cash items, except for changes in provision for losses on accounts receivable.

•Increases in accounts receivable resulted in a use of cash of $15.9 million and $22.6 million for the nine months ended September 30, 2024 and 2023, respectively. The decreased use of cash for each of the nine month periods is due primarily to the timing of sales and collection of cash related thereto within the periods. Days sales outstanding of receivables increased one day through the nine months ended September 30, 2024, and increased by five days through the nine months ended September 30, 2023.

•We increased our investment in inventory by $23.1 million for the nine months ended September 30, 2024, while we decreased our investment in inventory by $1.8 million for the nine months ended September 30, 2023. Our days sales in inventory increased by four days through the nine months ended September 30, 2024, as we continued to manage inventory levels, considering our supply needs, and balanced with sales growth within our Packaging and Aerospace segments. Our days sales in inventory decreased by two days through the nine months ended September 30, 2023, primarily as a result of moderating inventory levels with sales level.

•Increases in prepaid expenses and other assets resulted in a use of cash of $4.6 million and $0.7 million for the nine months ended September 30, 2024, and 2023, respectively. These changes were primarily a result of the timing of payments made for income taxes and certain operating expenses.

•Decreases in accounts payable and accrued liabilities resulted in a use of cash of $7.0 million and $10.4 million for the nine months ended September 30, 2024 and 2023, respectively. Days accounts payable on hand decreased by nine days through the nine months ended September 30, 2024 and decreased by eight days for the nine months ended September 30, 2023. Our days accounts payable on hand fluctuate primarily as a result of the timing of payments made to suppliers and the mix of vendors and related terms.

Net cash used for investing activities for the nine months ended September 30, 2024 and 2023 was $31.9 million and $111.8 million, respectively. During the first nine months of 2024, we invested $36.0 million in capital expenditures, as we continued our investment in growth, capacity and productivity-related capital projects. We also received net proceeds of $4.1 million from disposition of property and equipment. During the first nine months of 2023, we invested $34.9 million in capital expenditures, paid $77.3 million, net of cash acquired, to acquire Aarts and Weldmac, and received net proceeds of $0.5 million from disposition of property and equipment.

Net cash used for financing activities was $12.8 million and $23.2 million for the nine months ended September 30, 2024 and 2023, respectively. During the nine months ended September 30, 2024, we received net proceeds of $13.4 million from borrowings on our revolving credit facilities, purchased $19.3 million of our outstanding common stock, used a net cash amount of $1.6 million related to our stock compensation arrangements, paid dividends of $5.0 million, and paid $0.3 million related to other financing activities. Our reported net proceeds from borrowings on our revolving credit facilities considers the impact of foreign currency translation. During the nine months ended September 30, 2023, we received net proceeds of $1.1 million from borrowings on our revolving credit facilities, purchased $13.4 million of outstanding common stock, used a net cash amount of $2.7 million related to our stock compensation arrangements, paid dividends of $5.0 million, and paid $3.2 million related to liabilities assumed in our acquisition of Aarts.

36

---

Table of Contents

Our Debt and Other Commitments

In March 2021, we issued $400.0 million aggregate principal amount of 4.125% senior notes due April 15, 2029 ("Senior Notes") at par value in a private placement under Rule 144A of the Securities Act of 1933, as amended ("Securities Act"). The Senior Notes accrue interest at a rate of 4.125% per annum, payable semi-annually in arrears on April 15 and October 15. The payment of principal and interest is jointly and severally guaranteed, on a senior unsecured basis, by certain subsidiaries of the Company. The Senior Notes are pari passu in right of payment with all existing and future senior indebtedness and effectively subordinated to all existing and future secured indebtedness to the extent of the value of the assets securing such indebtedness.

We may redeem all or part of the Senior Notes at the redemption prices (expressed as percentages of principal amount) set forth below, plus accrued and unpaid interest, if any, to the redemption date, if redeemed during the twelve-month period beginning on April 15 of the years indicated below:

Year						Percentage
2024						102.063		%
2025						101.031		%
2026 and thereafter						100.000		%

For the nine months ended September 30, 2024, our consolidated subsidiaries that do not guarantee the Senior Notes represented 30% of the total of guarantor and non-guarantor net sales, treating each as a consolidated group and excluding intercompany transactions between guarantor and non-guarantor subsidiaries. In addition, our non-guarantor subsidiaries represented 37% and 12% of the total guarantor and non-guarantor assets and liabilities, respectively, as of September 30, 2024, treating the guarantor and non-guarantor subsidiaries each as a consolidated group.

We are party to a credit agreement ("Credit Agreement") consisting of a $300.0 million senior secured revolving credit facility, which permits borrowings denominated in specific foreign currencies, subject to a $125.0 million sub limit, maturing on March 29, 2026. The Credit Agreement is subject to benchmark interest rates determined based on the currency denomination of borrowings, with British pound sterling borrowings subject to the Sterling Overnight Index Average and Euro borrowings to the Euro InterBank Offered Rate (“EURIBOR”), both plus a spread of 1.75%, and U.S. dollar borrowings subject to the Secured Overnight Financing Rate ("SOFR") plus a spread of 1.85%. The interest rate spread is based upon the leverage ratio, as defined, as of the most recent determination date. Our revolving credit facility allows for the issuance of letters of credit, not to exceed $40.0 million in aggregate.

The Credit Agreement provides for incremental revolving credit commitments in an amount not to exceed the greater of $200.0 million and an amount such that, after giving effect to such incremental commitments and the incurrence of any other indebtedness substantially simultaneously with the making of such commitments, the senior secured net leverage ratio, as defined in the Credit Agreement, is no greater than 3.00 to 1.00. The terms and conditions of any incremental revolving credit facility commitments must be no more favorable than the existing credit facility.

Amounts drawn under our revolving credit facility fluctuate daily based upon our working capital and other ordinary course needs. Availability under our revolving credit facility depends upon, among other things, compliance with our Credit Agreement's financial covenants. Our Credit Agreement contains various negative and affirmative covenants and other requirements affecting us and our subsidiaries, including the ability to, subject to certain exceptions and limitations, incur debt, liens, mergers, investments, loans, advances, guarantee obligations, acquisitions, asset dispositions, sale-leaseback transactions, hedging agreements, dividends and other restricted payments, transactions with affiliates, restrictive agreements and amendments to charters, bylaws, and other material documents. The terms of our Credit Agreement require us and our subsidiaries to meet certain restrictive financial covenants and ratios computed quarterly, including a maximum total net leverage ratio (total consolidated indebtedness plus outstanding amounts under the accounts receivable securitization facility, less the aggregate amount of certain unrestricted cash and unrestricted permitted investments, as defined, over consolidated EBITDA, as defined) and a minimum interest expense coverage ratio (consolidated EBITDA, as defined, over the sum of consolidated cash interest expense, as defined, and preferred dividends, as defined). Our permitted total net leverage ratio under the Credit Agreement is 4.00 to 1.00 as of September 30, 2024. If we were to complete an acquisition which qualifies for a Covenant Holiday Period, as defined in our Credit Agreement, then our permitted total net leverage ratio cannot exceed 4.50 to 1.00 during that period. Our actual total net leverage ratio was 2.76 to 1.00 at September 30, 2024. Our permitted interest expense coverage ratio under the Credit Agreement is 3.00 to 1.00 as of September 30, 2024. Our actual interest expense coverage ratio was 8.18 to 1.00 at September 30, 2024. At September 30, 2024, we were in compliance with our financial covenants.

37

---

Table of Contents

The following is a reconciliation of net income, as reported, which is a GAAP measure of our operating results, to Consolidated Bank EBITDA, as defined in our Credit Agreement, for the twelve months ended September 30, 2024 (dollars in thousands). We present Consolidated Bank EBITDA to show our performance under our financial covenants.

																								Twelve Months Ended  September 30, 2024
Net income																								$	26,550
Bank stipulated adjustments:
Interest expense																								19,310
Income tax expense																								5,130
Depreciation and amortization																								56,530
Non-cash compensation expense(1)																								8,400
Other non-cash expenses or losses																								170
Non-recurring expenses or costs(2)																								21,960
Extraordinary, non-recurring or unusual gains or losses																								8,530
Effects of purchase accounting adjustments																								400
Business and asset dispositions																								(770)
Currency gains and losses																								1,250
Consolidated Bank EBITDA, as defined																								$	147,460

			September 30, 2024
Total Indebtedness, as defined(3)			$	406,510
Consolidated Bank EBITDA, as defined			147,460
Total net leverage ratio			2.76			x
Covenant requirement			4.00			x

																								Twelve Months Ended  September 30, 2024
Interest expense																								$	19,310
Bank stipulated adjustments:
Interest income																								(340)
Non-cash amounts attributable to amortization of financing costs																								(950)
Total Consolidated Cash Interest Expense, as defined																								$	18,020

			September 30, 2024
Consolidated Bank EBITDA, as defined			$	147,460
Total Consolidated Cash Interest Expense, as defined			18,020
Actual interest expense coverage ratio			8.18			x
Covenant requirement			3.00			x

_____________________________

(1)    Non-cash compensation expenses resulting from the grant of equity awards.

(2)    Non-recurring costs and expenses relating to diligence and transaction costs, strike related costs, severance, relocation, restructuring and curtailment expenses.

(3)    Includes $4.5 million of acquisition-related contingent consideration, $3.5 million of derivative liabilities, and $1.9 million of finance leases as of September 30, 2024.

38

---

Table of Contents

At September 30, 2024, we had $13.5 million outstanding under our revolving credit facility and had $280.2 million potentially available after giving effect to $6.3 million of letters of credit issued and outstanding. At December 31, 2023, we had no amounts outstanding under our revolving credit facility and had $294.0 million potentially available after giving effect to $6.0 million of letters of credit issued and outstanding. Our letters of credit are used for a variety of purposes, including support of certain operating lease agreements, vendor payment terms and other subsidiary operating activities, and to meet various states' requirements to self-insure workers' compensation claims, including incurred but not reported claims. After consideration of leverage restrictions contained in the Credit Agreement, as of September 30, 2024 and December 31, 2023, we had $183.3 million and $256.9 million, respectively, of borrowing capacity available for general corporate purposes.

We rely upon our cash flow from operations and available liquidity under our revolving credit facility to fund our debt service obligations and other contractual commitments, working capital and capital expenditure requirements. At the end of each quarter, we have historically used cash on hand from our domestic and foreign subsidiaries to pay down amounts outstanding under our revolving credit facility, as applicable.

Our weighted average borrowings during the first nine months of 2024 approximated $437.5 million, compared to $420.5 million during the first nine months of 2023, primarily due to borrowings made on our revolving credit facility.

In May 2021, we, through one of our non-U.S. subsidiaries, entered into a revolving loan facility with a borrowing capacity of $4.0 million. The facility is guaranteed by TriMas Corporation. At September 30, 2024, we had $0.1 million outstanding on this loan facility.

Cash management related to our revolving credit facility is centralized. We monitor our cash position and available liquidity on a daily basis and forecast our cash needs on a weekly basis within the current quarter and on a monthly basis outside the current quarter over the remainder of the year. Our business and related cash forecasts are updated monthly.

While the majority of our cash on hand as of September 30, 2024 is located outside of the U.S., given available funding under our revolving credit facility of $183.3 million at September 30, 2024 (after consideration of the aforementioned leverage restrictions) and based on forecasted cash sources and requirements inherent in our business plans, we believe that our liquidity and capital resources, including anticipated cash flows from operations, will be sufficient to meet our debt service, capital expenditure and other short-term and long-term obligations for the foreseeable future, as well as dividends and share repurchases.

We are subject to variable interest rates on our revolving credit facility, which is subject to a benchmark interest rate determined based on the currency denomination of borrowings. At September 30, 2024, the 1-Month SOFR approximated 5.0% and the Prime rate approximated 8.0%. Based on our variable rate-based borrowings outstanding at September 30, 2024, a 1% increase in the per annum interest rate would increase our interest expense by $0.1 million annually.

In addition to our long-term debt, we have other cash commitments related to leases. The majority of our lease transactions are accounted for as operating leases, and annual rent expense related thereto approximated $14.9 million in 2023. We expect leasing will continue to be an available financing option to fund future capital expenditure requirements.

As part of our first quarter 2023 acquisition of Aarts, we assumed a $2.9 million liability to a bank related to the advance funding of certain accounts receivable invoices. We terminated this arrangement, and repaid the outstanding balance, in March 2023.

In March 2020, we announced our Board of Directors had authorized us to increase the purchase of our common stock up to $250 million in the aggregate. In the nine months ended September 30, 2024, we purchased 771,067 shares of our outstanding common stock for an aggregate purchase price of $19.3 million. Since the initial authorization through September 30, 2024, we have purchased 6,566,564 shares of our outstanding common stock for an aggregate purchase price of $182.4 million. We will continue to evaluate opportunities to return capital to shareholders through the purchase of our common stock and the payment of dividends, depending on market conditions, and other factors.

Market Risk

We conduct business in various locations throughout the world and are subject to market risk due to changes in the value of foreign currencies. The functional currencies of our foreign subsidiaries are primarily the local currency in the country of domicile. We manage these operating activities at the local level and revenues and costs are generally denominated in local currencies; however, results of operations and assets and liabilities reported in U.S. dollars will fluctuate with changes in exchange rates between such local currencies and the U.S. dollar.

39

---

Table of Contents

We use derivative financial instruments to manage currency risks associated with our procurement activities denominated in currencies other than the functional currency of our subsidiaries and the impact of currency rate volatility on our earnings. As of September 30, 2024, we were party to foreign exchange forward and swap contracts to hedge changes in foreign currency exchange rates with notional amounts of $141.9 million. We also use cross-currency swap agreements to mitigate currency risks associated with the net investment in certain of our foreign subsidiaries. See Note 10, "Derivative Instruments," included in Part 1, Item 1, "Notes to Unaudited Consolidated Financial Statements," within this quarterly report on Form 10-Q for additional information.

We are also subject to interest risk as it relates to our long-term debt. We have historically used interest rate swap agreements to fix the variable portion of our debt to manage this risk.

Common Stock

TriMas is listed in the NASDAQ Global Select Market. Our stock trades under the symbol "TRS."

Credit Rating

We and certain of our outstanding debt obligations are rated by Standard & Poor's and Moody's. On March 19, 2024, Moody's affirmed a Ba3 rating to our Senior Notes. See Note 9, "Long-term Debt" included in Part I, Item 1, "Notes to Unaudited Consolidated Financial Statements" within this quarterly report on Form 10-Q. Moody's also affirmed a Ba2 Corporate Family Rating and maintained its outlook as stable. On June 28, 2024, Standard & Poor's affirmed a BB- rating to our Senior Notes. Standard & Poor's also affirmed a BB corporate credit rating and maintained its outlook as stable. If our credit ratings were to decline, our ability to access certain financial markets may become limited, our cost of borrowings may increase, the perception of us in the view of our customers, suppliers and security holders may worsen and as a result, we may be adversely affected.

Outlook

In 2023, we proactively managed through demand weakness in certain of our packaging businesses and an imbalance of high demand against a lack of material and skilled labor availability in our aerospace businesses. While we believe supply-related production challenges are largely behind us in the Aerospace segment, we have further opportunity to improve our production throughput, and hence conversion, within our Packaging segment through the remainder of 2024 and into 2025. Within our Specialty Products segment, we currently are working through a significant demand trough as compared to the prior year period where we enjoyed exceptional sales rates and commercial strength. Within Specialty Products, we believe sales rates are firming up, and therefore, we anticipate sequential improvement in operating profit as we move forward based on structural costs saving actions we have implemented. We will continue to monitor trends in demand changes and adjust costs and investments accordingly.

We have seen a number of global market uncertainties stemming from the macro-economic environment in the past few years, including significant challenges in inflationary pressures, supply chain disruptions and labor availability, as well as significant volatility in our customers' sentiment and order patterns. While we expect a continued modest demand recovery in certain of our consumer products and industrial markets and continued strength in our aerospace & defense market, we remain cautious of the impact of global market uncertainty. However, no matter the outcome of these factors, we expect to continue to mitigate, as much as practical, the impact of these challenges, executing on streamlining actions and taking other steps as necessary, to maintain our strong balance sheet and generate cash in support of our capital allocation strategy.

We believe our capital structure remains strong and that we have sufficient headroom under our financial covenants, and ample cash and available liquidity under our revolving credit facility, to meet our debt service, capital expenditure and other short-term and long-term obligations for the next 12 months and for the foreseeable future, as well as fund dividends, share repurchases and bolt-on acquisitions consistent with our capital allocation strategy.

We expect to continue to leverage the tenets of our TriMas Business Model to manage our multi-industry businesses on a longer-term basis, achieve our growth plans, execute continuous improvement initiatives to offset inflationary pressures, and seek lower-cost sources for input costs, all while continuously assessing the appropriateness of our manufacturing footprint and fixed-cost structure.

Impact of New Accounting Standards

See Note 2, "New Accounting Pronouncements," included in Part 1, Item 1, "Notes to Unaudited Consolidated Financial Statements," within this quarterly report on Form 10-Q.

40

---

Table of Contents

Critical Accounting Policies

Certain of our accounting policies require the application of significant judgment by management in selecting the appropriate assumptions used in calculating financial estimates. By their nature, these judgments are subject to an inherent degree of uncertainty. These judgments are based on our historical experience, our evaluation of business and macroeconomic trends, and information from other outside sources, as appropriate.

During the quarter ended September 30, 2024, there were no material changes to the items that we disclosed as our critical accounting policies in Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations," in the Annual Report on Form 10-K for the year ended December 31, 2023.

41

---

Table of Contents

Item 3.    Quantitative and Qualitative Disclosures About Market Risk

In the normal course of business, we are exposed to market risk associated with fluctuations in foreign currency exchange rates. We are also subject to interest risk as it relates to long-term debt. See Part I, Item 2, "Management's Discussion and Analysis of Financial Condition and Results of Operations," for details about our primary market risks, and the objectives and strategies used to manage these risks. Also see Note 9, "Long-term Debt," and Note 10, "Derivative Instruments," in Part I, Item 1, "Notes to Unaudited Consolidated Financial Statements," included within this quarterly report on Form 10-Q for additional information.

Item 4.    Controls and Procedures

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports that the Company files or submits under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is recorded, processed, summarized, and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to the Company's management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.

Evaluation of disclosure controls and procedures

As of September 30, 2024, an evaluation was carried out by management, with the participation of the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the Company's disclosure controls and procedures (as such term is defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act) pursuant to Rule 13a-15 of the Exchange Act. The Company's disclosure controls and procedures are designed only to provide reasonable assurance that they will meet their objectives. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that as of September 30, 2024, the Company's disclosure controls and procedures are effective to provide reasonable assurance that they would meet their objectives.

Changes in internal control over financial reporting

There have been no changes in the Company's internal control over financial reporting during the quarter ended September 30, 2024 that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

42

---

Table of Contents

PART II. OTHER INFORMATION

TRIMAS CORPORATION

Item 1.    Legal Proceedings

See Note 13, "Commitments and Contingencies," included in Part I, Item 1, "Notes to Unaudited Consolidated Financial Statements," within this quarterly report on Form 10-Q.

Item 1A.    Risk Factors

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part 1, Item 1A., "Risk Factors," in our 2023 Annual Report on Form 10-K, which could materially affect our business, financial condition or future results. There have been no significant changes in our risk factors as disclosed in our 2023 Annual Report on Form 10-K.

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides information about purchases made by the Company, or on behalf of the Company by an affiliated purchaser, of shares of the Company's common stock during the three months ended September 30, 2024:

Period						Total Number of Shares Purchased						Average Price Paid per Share						Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1)						Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program (in millions) (1)
July 1, 2024 to July 31, 2024						14,704						$	24.97					14,704						$	69.7
August 1, 2024 to August 31, 2024						63,000						$	24.24					63,000						$	68.2
September 1, 2024 to September 30, 2024						21,426						$	24.90					21,426						$	67.6
Total						99,130						$	24.49					99,130						$	67.6

__________________________

(1)     In March 2020, the Company announced its Board of Directors had authorized the Company to increase the purchase of its common stock up to $250 million in the aggregate from its previous authorization of $150 million. The increased authorization includes the value of shares already purchased under the previous authorization. Pursuant to this share repurchase program, during the three months ended September 30, 2024, the Company repurchased 99,130 shares of its common stock at a cost of $2.4 million. The share repurchase program is effective and has no expiration date.

Item 3.    Defaults Upon Senior Securities

Not applicable.

Item 4.    Mine Safety Disclosures

Not applicable.

Item 5.    Other Information

During the quarter ended September 30, 2024, no director or officer (as defined in Rule 16a-1(f) promulgated under the Exchange Act) of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” (as each term is defined in Item 408 of Regulation S-K).

43

---

Table of Contents

Item 6.    Exhibits

Exhibits Index:

3.1			Fourth Amended and Restated Certificate of Incorporation of TriMas Corporation (Incorporated by reference to the Exhibits filed with TriMas Corporation's Quarterly Report on Form 10-Q filed on August 3, 2007 (File No. 001-10716)).
3.2			Third Amended and Restated By-laws of TriMas Corporation (Incorporated by reference to the Exhibits filed with TriMas Corporation's Current Report on Form 8-K filed on December 18, 2015 (File No. 001-10716)).
31.1			Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002.
31.2			Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002.
32.1			Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes‑Oxley Act of 2002.
32.2			Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes‑Oxley Act of 2002.
101			The following materials from TriMas Corporation's Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheet, (ii) the Consolidated Statement of Income, (iii) the Consolidated Statement of Comprehensive Income, (iv) the Consolidated Statement of Cash Flows, (v) the Consolidated Statement of Shareholders' Equity, (vi) Notes to Consolidated Financial Statements, and (vii) document and entity information.
104			Cover Page Interactive Data File (embedded within the Inline XBRL document)

44

---

Table of Contents

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

TRIMAS CORPORATION (Registrant)

/s/ SCOTT A. MELL

Date:

November 4, 2024

By:

Scott A. Mell Chief Financial Officer

45